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Studies have been conducted on the membrane-associated ribonu¬
cleotide reductase from Pseudomonas stutzeri (P. stutzeri) with the
aim of identifying the polypeptides comprising the enzyme and
localizing the allosteric and substrate binding sites. Photoaffinity
labeling using [^^P]-labeled dTTP, dGTP, and dCTP as allosteric
site-directed probes has identified two distinct allosteric binding
sites on 82 K and 78 K polypeptides. Polyclonal antibodies raised
against these polypeptides have been used to precipitate the ribo¬
nucleotide reductase activity of P. stutzeri extracts. 8-azido-ATP has
been used to photolabel a possible substrate binding site on a 57 K
polypeptide.
Kinetic studies have been used to support the results obtained
in photoaffinity labeling experiments. Substrate reduction as a
function of deoxyribonucleotide concentration has confirmed the
existence of two binding sites with different affinities for deoxy-
ribonucleotides. Substrate saturation curves constructed over a wide
1
range of substrate concentrations have demonstrated a complex pattern
of negative and positive cooperativity and inhibition studies using
alternative substrates have indicated mixed-type inhibition. A
mechanism for substrate reduction involving at least two nonidentical
substrate binding sites is suggested.
A model consisting of two subunits for the ribonucleotide re¬
ductase from P. stutzeri has been proposed. The allosteric subunit
is proposed to be comprised of the 82 K and 78 K polypeptides which
contain two distinct allosteric binding sites. The second subunit is
proposed to be comprised of two 57 K polypeptides which are involved
in substrate binding. The model presented suggests a similar struc¬
ture for the ribonucleotide reductase enzymes from P. stutzeri and
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INTRODUCTION
Ribonucleotide reductase is an allosteric enzyme which cata¬
lyzes the irreversible conversion of ribonucleotides to their cor¬
responding deoxyribonucleotides.^ This reaction is a vital one to
all living organisms because it provides a balanced supply of the
four deoxyribonucleotides required for DNA synthesis. Ribonucleo¬
tide reductase activity has been shown to be cell cycle dependent
and to increase markedly as cells enter the S phase, in which DNA
synthesis occurs.Several studies have provided evidence
that ribonucleotide reductase plays an important role in regulating
DNA synthesis. Fuchs et al.^»® generated a conditional lethal
mutant of E. coli (dnaF) which carried a defective structural gene
for ribonucleotide reductase. They observed that the mutant cells
were unable to synthesize DNA at the restrictive temperature, as
indicated by cell death. The ribonucleotide reductase activity in
these cells was shown to be temperature sensitive. In very early
studies, Biswas et al.^ found that deprivation of thymine in an E.
coli thymine auxotroph resulted in an increased synthesis of ribo¬
nucleotide reductase. Other studies by Filpula and Fuch® con¬
firmed the effect of thymine deprivation on E. coli ribonucleotide
reductase activity, and reported that other conditions which cause
pertubation of DNA synthesis such as treatment with nalidixic acid
or bleomycin, specific inhibitors of DNA synthesis, also resulted
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in increased synthesis of ribonucleotide reductase. Growth of mouse
fibroblast 3T6 cells in media containing hydroxyurea, a free radical
scavenger, resulted in a blockage of DNA synthesis.^ This blockage
of DNA synthesis was attributed to depletion of the deoxyribonucleo-
tide pools caused by inactivation of the radical-containing M2
subunit of the mammalian ribonucleotide reductase enzyme. These
data and data from similar studies have suggested a key role for
ribonucleotide reductase in DNA synthesis. Studies aimed at provid¬
ing a better understanding of the structural and regulatory proper¬
ties of this enzyme are therefore of major importance in the field
of biochemistry.
Ribonucleotide reductase has been purified to homogeneity from
a number of prokaryotic systems including E. coli
Lactobacillus leichmannii (L. leichmannii1.and phage in¬
fected E. coliThe enzyme has been partially purified
from Rhizobium melilotiCorvnebacterium neohridiiherpes
simplex virus type and from several eukaryotic organisms
including the yeast, Saccharomvces cerevisiae.^^ calf thymus,
rabbit bone marrow,mouse T-lymphoma (S49) cells,and Euolena
gracilis.Chang and Cheng^^ have obtained the partially purified
enzyme from cultured human lymphoblast cells. Homogeneous purifica¬
tion of the enzyme from mammalian sources has proven difficult.
Recently, however, a homogeneous preparation of the mouse M2 sub¬
unit was obtained by affinity chromatography on an anti-tubulin
antibody-Sepharose column.^®
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Two major classes of ribonucleotide reductases have been de¬
scribed based upon cofactor requirement.^ One class, represented
by the enzyme from E. coli. requires iron as a cofactor and uses
ribonucleoside diphosphates as substrates. The reductase enzymes
from mammalian cells and from yeast have been grouped into this
category. The second class of reductase requires deoxyadenosyl-
cobalamin as a cofactor and uses ribonucleoside triphosphates as
substrates. This class is represented by the enzyme from i,.
leichmannii and includes the enzymes from Euolena and P.
stutzeriThe ribonucleotide reductase enzymes from Corvnebac-
terium neohridii and Rhizobium meliloti also require deoxyadenosyl-
cobalamin as a cofactor, but use ribonucleoside diphosphates as
substrates. Tsai and Hogenkamp^® have suggested that the enzyme
from Corvnebacterium neohridii may represent an intermediate be¬
tween the deoxyadenosylcobalamin-dependent reductase found in L.
leichmannii and the "more evolutionarily advanced"^® iron-
dependent reductase of E. coli.
The ribonucleotide reductase enzyme from E. coli has been
studied in great detail and fully characterized. This protein has a
molecular weight of 245,000 dal tons and is comprised of two non¬
identical subunits designated B1 and B2.^^ The 160,000 dalton B1
subunit was found by Thelander^^ to be composed of two nearly
identical polypeptides, designated as a and a'» which have identi¬
cal carboxy terminal amino acids, but different amino terminal
ends. The B1 subunit was found to be encoded by the nrdA gene
which codes for a 776 amino acid polypeptide chain with a molecular
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weight of 87,532.^® Formation of the two similar polypeptides of
the B1 subunit is believed have resulted from processing of the
translation product of the nrdA transcript by removal of amino
terminal amino acid residues.The B1 subunit has been shown to
contain two thiols which are oxidized to a disulfide during the
enzymatic reaction.Both the allosteric effector binding
sites^^ and the substrate binding sites^® have been localized
to the B1 subunit.
The B2 subunit of ribonucleotide reductase from E. coli has a
molecular weight of 78,000^^ and is comprised of two identical
polypeptides designated as 02* ^he B2 subunit was shown to be
encoded by the nrdB gene which codes for a 375 amino acid polypep¬
tide with a molecular weight of 43,466.^® The B2 subunit was
shown to contain two antiferromagnetically coupled ferric ions and
a tyrosyl free radical.
Studies have shown that both the B1 and B2 subunits of E.
coli ribonucleotide reductase are required for enzymic activity.
The two subunits were shown to be inactive when separate, but
formed the active enzyme when combined in a 1:1 ratio in the pre¬
sence of magnesium ion.^^ Thelander et al.^^ proposed a model
in which the active site of the enzyme is formed from the combina¬
tion of both the B1 and the B2 subunits. In this structure, the
dithiols of B1 are considered to be in close contact with the free
radical of B2 to facilitate the reduction reaction.
The deoxyadenosylcobalamin-dependent ribonucleotide reductase
from JL. leichmannii has also been studied in detail. This enzyme
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consists of a single polypeptide chain with a molecular weight of
76,000.^^ In direct binding studies, Chen et al.^^ have shown that
this ribonucleotide reductase contains one binding site for deoxy-
ribonucleotide effectors.A substrate binding site unique from
the effector binding site has been proposed but has not been demon¬
strated in direct binding studies. It has also been reported that
the enzyme contains a binding site for the coenzyme, deoxyadeno-
sylcobalamin.^^
Both the iron-dependent and the deoxyadenosylcobalamin-
dependent ribonucleotide reductases appear to have a common
mechanism for reduction of ribonucleotides. It is suggested that
the reduction reaction proceeds by a radical mechanism in which the
OH group at the V position on the ribose sugar moiety of the
ribonucleotide substrate is replaced by a hydrogen atom from the
solvent.During reduction of the substrate, two thiol groups
on the enzyme are oxidized to a disulfide.^® In vivo the dithiol
is regenerated by small proteins which act as hydrogen carriers,
with NADPH as the ultimate hydrogen donor. In vitro an added
dithiol such as dithiothreitol can replace the hydrogen transport
system to regenerate the enzymic dithiol.
The mechanism of the reduction of ribonucleotides by the ribo¬
nucleotide reductase enzyme has been studied in some detail. It
has been shown that the reaction occurs with retention of configuration
at the 1' position of the ribonucleotide substrate.Re¬
sults from ESR studies have suggested that both the iron-dependent
enzyme from E. coliand the deoxyadenosylcobalamin-dependent
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enzyme from L. leichmanniare capable of cleaving the 3' C-H
bond of the substrate to form a substrate radical intermediate.
Evidence from these and other studies has suggested that forma¬
tion of the substrate radical intermediate by the deoxyadenosyl-
cobalamin-dependent ribonucleotide reductase and the iron-dependent
ribonucleotide reductase occurs by different processes. Stubbe et
al.^® have postulated that the deoxyadenosylcobalamin cofactor
serves as a radical chain initiator in the formation of the sub¬
strate radical. They proposed that the 5'deoxyadenosyl radical,
produced through cleavage of the carbon-cobalt bond, abstracts an H
from an amino acid residue on the enzyme, which in turn abstracts
an H from the nucleotide substrate to yield the substrate radical.
For the iron-dependent enzyme, the proposed process for substrate
radical formation involves direct abstraction of the 3' H of the
substrate by the tyrosyl radical
In most of the organisms studied, a single ribonucleotide re¬
ductase enzyme is capable of reducing all four of the substrates.^
In some cases, however, purification of the enzyme has resulted in
separation of multiple forms of the enzyme with activities specific
for a certain ribonucleotide substrate. Morita et al.^^ were
able to separate the CDP reductase from the cytosol of rat Yoshida
ascites sarcoma through acidification. The resultant precipitate
contained the CDP reductase activity while the ADP, GDP, and UDP
activities remained in the supernatant. Youdale and MacManus,^^
using dATP-Sepharose chromatography, isolated a subunit of the
ribonucleotide reductase from regenerating rat liver which was
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specific for the reduction of CDP. In studies of UDP (UTP) reduc¬
tion in rat hepatomas, Blocker and Roth found that the UDP (UTP)
reductase activity was not affected by concentrations of hydroxy¬
urea which completely inhibited the CDP reductase activity.The
authors concluded that these results suggested the existence of two
different forms of the enzyme for reduction of UDP and CDP.
Further evidence for multiple forms of the ribonucleotide re¬
ductase enzyme has come from studies of the enzyme from Ehrlich's
tumor cells. Cory and Fleischer^® demonstrated the presence of
two forms of the ribonucleotide reductase enzyme following sedimen¬
tation equilibrium analysis. The CDP reductase had a molecular
weight of 304,000, and the ADP reductase had a molecular weight of
254,000. Further changes in the observed molecular weights of the
two enzyme forms were observed upon addition of the substrate speci¬
ficity effectors, ATP and dGTP, for reduction of CDP and ADP,
respectively. Cory and Mansell^^ noted significant differences
in several properties of the ADP and CDP reductase activities, in¬
cluding different Mg'*’^ requirements, different responses to enzyme
inhibitors, and different ratios of the two activities during the
purification. In earlier studies, Cory observed that CDP reduction
was not inhibited by the addition of UDP, despite the fact that
reduction of CDP and UDP was activated by the same allosteric ef¬
fector.^® These studies suggest that multiple forms of ribonucleo¬
tide reductase may exist in some organisms.
One of the most complex aspects of the ribonucleotide reduc¬
tase enzyme is its allosteric regulatory properties. Reduction of
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each of the four substrates by ribonucleotide reductase is maximal¬
ly stimulated by a specific allosteric effector. In E. coli the
reduction of each substrate was shown to be regulated by binding
of a specific deoxyribonucleotide or ATP at the allosteric site.
ATP (or dATP at low concentration) stimulated the reduction of CDP
and UDP; dTTP the reduction of GDP; and dGTP the reduction of
ADP.^2 a similar pattern of activation was observed for the
mammalian ribonucleotide reductase from calf thymus, except that
dATP was shown to be an inhibitor of ribonucleotide reduction even
at low concentrations.^® It has been shown that the reduction of
the ribonucleoside triphosphate substrates of the deoxyadenosylco-
balamin-dependent reductase from i. leichmannii is also regulated
by deoxyribonucleotides: dATP for CTP reduction; dTTP for GTP
reduction; dGTP for ATP reduction; and dCTP for UTP reduction.^®
The allosteric regulatory properties of the ribonucleotide re¬
ductase enzyme have been described in detail by Thelander in
studies of the E. coli enzyme.Thelander proposed a model in
which two types of allosteric sites exist on the enzyme. The
1-sites were proposed as low affinity sites which bound only dATP,
an inhibitor, or ATP, an activator. Binding at these sites regulat¬
ed the overall activity of the enzyme. The h-sites were identified
as high affinity sites based upon dATP binding. Binding at these
sites activated reduction of a specific ribonucleotide substrate.
Evidence has been obtained by Eriksson et al.^^ to support the
existence of two allosteric regulatory domains on the Ml subunit of
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the mouse ribonucleotide reductase. The domains exhibited affinity
properties similiar to the 1- and h-sites of the E. coli enzyme.
It has been suggested that the cytotoxic effects observed in
several human immunodeficiency diseases may be the result of the
effect of accumulated deoxyribonucleotides on the ribonucleotide
reductase enzyme.Studies of cells from patients who had
a severe combined immunodeficiency disease in which both T-and
B-cell functions were impaired have shown a deficiency of adenosine
deaminase.Adenosine deaminase catalyzes deamination of adeno¬
sine and deoxyadenosine to inosine and deoxyinosine. In studies in
which adenosine deaminase deficiency was artificially induced by
inhibitors of the enzyme, a greatly elevated level of dATP was
observed in erythrocytes, lymphocytes, and bone marrow.Studies
have shown that inhibition of adenosine deaminase and the concom-
mitant accumulation of dATP, a potent inhibitor of the mammalian
ribonucleotide reductase enzyme, yielded a decrease in the sensiti¬
vity of ribonucleotide reductase to regulation by dATP.^^»^^
The cytotoxic effects observed in the inherited deficiency of
purine nucleoside phosphorylase have also been linked to altered
regulation of ribonucleotide reductase. Purine nucleoside phos¬
phorylase converts guanosine, deoxyguanosine, inosine, and deoxy¬
inosine to the appropriate purine base and either ribose- or
deoxyribose-1-phosphate. All four of the nucleoside substrates
have been found to accumulate in the urine of patients who lack
purine nucleoside phosphorylase.^^ An accumulation of dGTP in
the erythrocytes of patients who lack this enzyme has also been
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observed.It has been suggested that the accumulation of dGTP
causes a loss of feedback regulation of ribonucleotide reductase
by dGTP, and results in an imbalance in the regulation of the
ribonucleotide reductase enzyme.Mutants of ribonucleotide
reductase with altered dATP or dGTP regulatory properties have
been isolated and used as models for studying immunodeficiency
diseases.These studies demonstrate the importance of the
allosteric properties of the ribonucleotide reductase enzyme for
maintaining normal cell growth.
A major objective of biological research is to identify and to
characterize the molecular interactions which occur in biochemical
systems. A large number of interactions in biological systems
involve the binding of small organic molecules (ligands) to large
macromolecules (receptors). Various methods have been devised to
study the interaction between proteins and ligands. One such techni¬
que, affinity labeling, was developed in 1966 by Singer and
Doolittle.With this technique, a chemically labile ligand was
reversibly bound to the receptor to form the ligand-receptor com¬
plex. The reaction between functional groups at the binding site
resulted in the formation of a covalent bond. The use of a photo-
labile ligand which could be activated by irradiation has allowed
the utilization of this technique to probe and radioactively label
receptor sites in biological systems.
The use of photoaffinity labeling requires one to simulate the
natural ligand-receptor interaction as closely as possible. The
use of naturally photolabile ligands, which when exposed to
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ultraviolet light are inherently capable of generating chemical
intermediates that are highly reactive, has facilitated the use of
this technique. In 1977 Yue and Schimmel introduced the technique
of direct photoaffinity labeling using natural photolabile
nucleotides.^^ Radioactively labeled ATP was crosslinked to an
ami noacyl-tRNA synthetase by exposure to UV light. Since the
introduction of the direct labeling technique, nucleotides have
been used to directly label the catalytic site on heavy chains of
Acanthamoeba myosins,^® and the allosteric site of deoxycytidy-
late deaminase.^®
Direct photoaffinity labeling has also been applied to the
study of the nucleotide binding sites on the ribonucleotide reduc¬
tase protein. Martin and his colleagues used both [^^PJdTTP and
[^^P]dATP to label the ribonucleotide reductase allosteric bind¬
ing site of partially purified Ml subunit from mouse T-lymphoma
(S49) cells.In these studies, labeling by both dTTP and
dATP occurred exclusively at the allosteric binding site as deter¬
mined by competition of the labeling by other deoxyribonucleotides.
Although several other proteins in the partially purified prepara¬
tion were also labeled by dTTP and dATP, detailed studies by Martin
et al.®® showed that dTTP and dATP specifically labeled the allo¬
steric site on the Ml subunit.
Eriksson also utilized [^^P]dTTP and [^^PJdATP to label
the allosteric binding site of the purified ribonucleotide reduc¬
tase B1 subunit from E. coli enzyme.®^ In his study, Eriksson
found that both dTTP and dATP labeled the allosteric binding site.
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However, peptide mapping indicated that different peptides were
labeled by the two deoxyribonucleotides. In addition, Eriksson
observed that dTTP labeling was stimulated by the presence of
substrates for the ribonucleotide reductase enzyme. GDP, the
substrate for which reduction is activated by dTTP, showed the
greatest stimulation (approximately 3-fold) of the labeling of the
B1 subunit by
Direct photoaffinity labeling has also been utilized in an
attempt to localize the substrate binding site of the ribonucleo¬
tide reductase enzyme. The catalytic site of the mouse ribonucleo¬
tide reductase has been localized using [^^P]CDP as a photoaffi¬
nity probe.A substrate binding site on the Ml subunit was
specifically labeled by the substrate [^^P]CDP. This labeling
required the presence of the second subunit of the enzyme, the M2
subunit, as well as ATP, the positive allosteric activator for CDP
reduction. Labeling of the Ml subunit by CDP could be inhibited by
deoxyribonucleotides which did not serve as allosteric activators
of CDP reduction and by free radical scavengers which affected the
radical-containing M2 subunit.
8-Azidonucleotides constitute another group of photoaffinity
labeling reagents which have been widely used to study interactions
in biological system. These are synthetic compounds that are made
by placing an azido group (N3) at the 8-position on the purine
base of either adenosine or guanosine. Haley and Hoffman®^
pioneered use of 8-azidonucleotides in 1974 with the synthesis and
use of 8-azido-ATP as a photoaffinity label for the ATP binding
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sites of adenosine triphosphatase of human red cell membranes.
Since that time, 8-azido-ATP has been used to label a variety of
ATP binding sites. Haley et al.®^ have used azido-ATP to label the
ATP binding site on proteins as diverse as dynein polypeptides from
Chiamvdomonas^^ and terminal deoxynucleotidyltransferase.®®
Knight and McEntee used azido-ATP to label the ATP hydrolytic site
of the recA protein.®^ Campbell and MacLennan^® found that azido-
ATP specifically labeled high affinity ATP binding sites on several
glycoproteins of the sarcoplasmic reticulum of rabbit skeletal
muscle,®® while Carvalho-Alves et al.®® were able to distinguish
two distinct low and high affinity binding sites on the sarcoplas¬
mic reticulum ATPase using this probe.®® Azido-ATP has also been
extensively used to localize and probe the ATP binding sites on
ATPases from beef-heart mitochodria.^®"^® The successful use
of azido-ATP to probe these ATP binding sites made it a promising
choice to delineate the substrate binding sites of the ribonucleo¬
tide reductase protein in P. stutzeri.
The ribonucleotide reductase protein from P. stutzeri has been
studied in some detail by Holt et al.^^‘^® The enzyme was
shown to require deoxyadenosylcobalamin as a cofactor and ribonu-
cleoside triphosphates were the preferred substrates. In sedi¬
mentation analysis using discontinuous sucrose gradients, it was
shown that the ribonucleotide reductase activity in extracts of P.
stutzeri was associated with a high molecular weight macromolecular
component of the cell. This component sedimented in the sucrose
gradient at a density coincident with the inner membrane of P.
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stutzeri. Studies of this membrane-associated complex showed
that in addition to the ribonucleotide reductase activity, the
complex also contained 1ipopolysaccharides, RNA, and the
phospholipids, phosphatidylethanolamine and phosphatidylglycerol.
In addition, enzymes normally associated with the bacterial inner
membrane, namely NADH oxidase, lactate dehydrogenase, and succinate
74 75
dehydrogenase, were also found in this complex. ’
The major objective of the experiments described in this
dissertation was to determine the number and molecular weights of
the polypeptides that comprise the ribonucleotide reductase enzyme
isolated from the P. stutzeri membrane. The technique of photo¬
affinity labeling with radioactive probes was applied in this study
to identify the polypeptides that contained the nucleotide binding
sites in the membrane-associated complex containing the ribonucleo¬
tide reductase protein. Deoxyribonucleotides were used as allo¬
steric site-directed probes to localize the polypeptides that
contained the allosteric regulatory site{s) of the enzyme. Azido-
ATP was used as a substrate site-directed probe to identify poly¬
peptides that contained the enzyme's substrate-binding or catalytic
sites(s). Kinetic studies were employed in order to delineate the
number of substrate sites and the interaction of substrates mole¬
cules during the reduction reaction. Based on the results of these
studies, a model which accomodates the structural and kinetic
properties of the stutzeri ribonucleotide reductase is proposed.
MATERIALS AND METHODS
Materials
Ribonucleotides, deoxyribonucleotides, dithiothreitol, DNase
I, RNase A, alkaline phosphatase, and apyrase were purchased from
Sigma Chemical Company. 5-Deoxyadenosylcobalamin and BICINE were
the products of Calbiochem-Bering. Radioactive nucleotides
[a-22p]dcTP (650 Ci/mmol), [ a -^^P]dTTP (650 Ci/mmol),
[ a-^^P]dGTP (650 Ci/mmol), [ a-^^P]8-azido-ATP (20 Ci/mmol),
[^^C]ATP, and [^H]CTP were purchased from ICN Biomedicals, Inc.
All other reagents were purchased from usual vendors and were of
the highest grade commercially available. Emulgen 911 was a gift
from Dr. Cecil Pickett, Merck Sharpe & Dohme Research Laboratories,
Rahway, N.J.
Preparation of Protein Fraction
Pseudomonas stutzeri cells (ATCC 17588) were grown and har¬
vested as previously described.Cells were routinely stored
frozen at -70° and retained ribonucleotide reductase activity for
several years under these conditions.
A membrane fraction containing the ribonucleotide reductase
activity was prepared from frozen cell paste. The cells were lysed




to differential centrifugation as described previously. Brief¬
ly, 60 g of cells were suspended in 2 volumes of lysis buffer [0.05
M Tris HCl (pH 7.4), 0.1 M NaCl, 1 mM DTT, 0.3 M sucrose]. Lysozyme
and EDTA were added to a final concentration of 0.5 mg/ml and 10
mM, respectively. After 1 hr of stirring at 4°, the suspension
was heated at 37° for 15 min and then quickly chilled at 4°.
Magnesium sulfate (20 mM), and 2 mg each of DNase I and RNase A
were added and stirring was continued for 1 hr at 4°. The lysate
was centrifuged for 20 min at 39,000 x g to remove cell debris and
unbroken cells. The supernatant was then centrifuged at 100,000 x g
for 17 hr. The pellet was suspended in lysis buffer minus sucrose
and centrifuged at 39,000 x g for 20 min. The final pellet was
obtained by centrifugation of the supernatant from the above step
for 3.5 hr at 130,000 x g. This pellet was suspended in 0.1 M
Tris-HCl (pH 7.4) containing 1 mM DTT. Protein fractions to be
used in azido-ATP photoaffinity labeling experiments were dialyzed
to remove DTT.
Solubilization of Protein Fraction
For immunoprecipitation studies it was necessary to obtain a
nonparticulate protein preparation so that enzyme activity would
not be nonspecifically precipitated during centrifugation of the
immuno-complex. A solubilized protein preparation was obtained
from the protein fraction prepared as decribed above using the
following procedure.The protein fraction was homogenized in a
buffer containing 50% glycerol, 1 M Tris-acetate (pH 7.8), 0.2 mM
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DTT, 1 mM EDTA, and Emulgen 911 at a concentration of 1.5 ml/mg of
protein. Following centrifugation for 1 hr at 100,000 x g in a
Beckman SW 65 rotor, the supernatant was dialyzed against 0.1 M
Tris-HCl {pH 7.4) containing 1 mM DTT.
Protein Determination
Protein concentrations were determined by the method of Lowry
et al. with bovine serum albumin as the standard.^®
Ribonucleotide Reductase Assays
CTP reductase activity was measured in assay mixtures contain¬
ing 0.064 M BICINE buffer (pH 8.4), 0.031 M DTT, 0.002 M MgS04,
0.16 mM dATP, 0.004 mM DMBC, 0.4mM [^HJCTP, and from 0.1-1 mg
protein in a total volume of 0.25 ml. Following incubation at 37°
for 10 min, the samples were treated with 5.5 M perchloric acid and
dCMP was added as a carrier. Phosphates were cleaved by heating
the samples at 100° for 15 min, and the product was isolated as
deoxycytidine by chromatography on Dowex 50, H"*" form, as described
previously.Radioactivity contained in dCMP was measured by
counting 1 ml aliquots of the sample in 10 ml Ecoscint liquid
scintillation fluid (National Diagnostics, Highland Park, NJ).
The amount of product was calculated as previously described^^
and the specific activity was reported as nmol dCTP/min/mg protein.
ATP reductase activity was measured in standard assay mixtures
containing 0.04 M BICINE buffer (pH 8.4), 0.04 M DTT, 0.005 M
MgS04, 0.93 mM dGTP, 0.004 mM DMBC, 0.6 mM [^^CJATP, and from
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0.1 - 1 mg protein in a total volume of 0.2 ml. The concentration
of [^^C]ATP was varied and nucleotides were added to the assay
mixtures as indicated in figure legends. Mixtures were incubated
for 15 min at 30° followed by heating for 2 min at 100°. Tri¬
phosphates were cleaved by treatment with alkaline phosphatase
(0.015 unit, 1.5 g), and apyrase (0.012 unit, 100 g). The pro¬
duct was isolated as deoxyadenosine by thin layer chromatography on
MN-cellulose plates (Brinkmann Instruments, Westbury, NY). The
plates were pretreated with sodium borate as previously de¬
scribed.^^ Adenosine and deoxyadenosine ( 20 nmol each) were added
as carriers. Plates were developed in n-butanol:ammonium hydroxide
(10:3, v/v) as described by Knippers,®*^ and the spots, visualized
under UV light, were scraped into vials containing 1 ml of 1 M HCl.
Radioactivity was measured by counting in Ecoscint liquid scintilla¬
tion fluid. The amount of deoxyadenosine produced was calculated
as the ratio of counts in the deoxyadenosine to the total counts
recovered, multiplied by the amount of [^^C]ATP added initially.
Activity was reported as nmol dATP/min/mg protein.
Synthesis of Nonradioactive 8-Azido-ATP
Nonradioactive 8-azido-ATP was synthesized using a two-step
procedure in which ATP was converted into 8-bromo-ATP, which was
then converted into 8-azido-ATP. 8-bromo-ATP was synthesized as
described by Ikehara and Uesugi®^ as follows. One mmol of ATP
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was dissolved in 40 ml of 1 M acetate buffer (pH 4.0). To this
mixture 9.4 ml of saturated bromine-water was added and the mixture
was stirred overnight at room temperature. NaHS03 was added to
the mixture to remove excess bromine and the solution was evaporat¬
ed under reduced pressure at 30° to a volume of 1-2 ml. The
solution was diluted to 200 ml with water and the pH adjusted to
7.5. The products were separated by column chromatography on a
DEAE-Sephadex A-25-120 column (3 x 50 cm) and eluted with 2 liters
of a linear gradient of 0-1 M triethyl ammonium bicarbonate (TEAS)
buffer (pH 7.5). Fractions were collected in 9 ml and the absor¬
bance was recorded using a UV monitor. The fractions containing
Br-ATP were identified by the UV spectrum and by analysis on TLC.
TLC was performed on PEI-cellulose plates with fluorescent indica¬
tor, and the plates were developed in 1.5 M LiCl. Pooled fractions
containing Br-ATP were evaporated in vacuo at 30-35° to a volume
of 1-2 ml and washed several times with methanol to remove residual
TEAB. The sample was then lyophilized and stored under dessication.
8-Br-ATP was converted to 8-azido-ATP by treatment with tri-
ethylammonium azide as described by Schafer et al.®^ with modifi¬
cations.®^ Triethyl ammonium azide was prepared as follows. Tri-
ethylamine was slowly added to oven dried (85° for 6 hr) Dowex-Cl
in methanol. When heat was no longer emitted from the treated
resin, the resin was washed twice with anhydrous methanol (2 vol
each) and four times with distilled, anhydrous dimethylformamide (2
vol each). Triethyl ammonium azide was prepared by stirring 500 mg
(10 nmol) of LiN3 with the Dowex-tri ethyl ammonium resin (50 ml
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resin volume) for 1 hr at room temperature. After stirring, the
triethyl ammonium azide was collected by filtration of the resin
through a Buchner funnel under vacuum. Fifty ml of triethylam-
moniuum azide was mixed with 445 mg (0.5 nmol) of Br-ATP and
stirred for 18 hr at 75°. The reaction products were separated by
column chromatography using DEAE-Sephadex A-25-120. The column was
eluted with 2 liters of a linear gradient of 0-1 M TEAB buffer (pH
7.5). Fractions were collected in 10 ml and the UV absorbance at
279 nm was measured manually. The samples containing azido-
compounds were identified by their UV spectra. Azido-ATP was
distinguished from azido-ADP and azido-AMP based upon the relative
mobilities of these compounds during TLC analysis. The azido-ATP
fractions were pooled, evaporated jn vacuo at 30-35°, and lyophi-
lized. All manipulations involving the azido group were performed
under reduced light in order to avoid photodestruction of the azido
group.
Photoaffinitv Labeling With T^PldTTP. T^PldCTP.
and r—PldGTP
Reaction mixtures contained 70 mM Tris-HCl (pH 7.5), 5 mM
MgCl2, 2.5 mM DTT, 1.4 mg/ml protein, and either [^^P]dTTP,
[^^P]dCTP, or [^^P]dGTP (2-5/iCi) in a total volume of 30 /xl.
Nucleotides used in competition experiments were added as indicated
in the figure legends and were allowed to equilibrate with the
protein for 15 min prior to addition of the radioactive nucleotide.
Samples to be photolyzed were placed as drops on parafilm on ice in
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a Petri dish and allowed to equilibrate for 5 min. Photolysis was
performed by UV irradiation for 60 min (or as indicated in the
figure legend) using a Minerallight Lamp (Model R-52 Ultraviolet
Products, San Gabriel, CA) which was placed 10 cm from the samples.
Following photolysis 100 nmol of nonradioactive deoxyribonucleotide
was added to each sample. Individual samples were treated as
indicated in the figure legend prior to electrophoresis and auto¬
radiography.
Photoaffinity Labeling With F—P18-Azido-ATP
The procedure used was essentially the same as described above
except that DTT was omitted, and the reaction mixtures contained
2-5 MCi of [^^P]azido-ATP. The samples were photolyzed for 10 min
and following photolysis 200 nmol ATP was added to each sample.
The samples were analyzed by electrophoresis and autoradiography.
Electrophoresis and Autoradiography
Protein samples were mixed with sample buffer containing 62.5
mM Tris-HCl (pH 6.8), 1.25% SDS, 1.25% 2-mercaptoethanol, 12.5%
glycerol, and 0.1% bromophenol blue. Following heat denaturation
at 95° for 10 min, the samples were analyzed by electrophoresis on
7% polyacrylamide gels containing 0.1% SDS using the discontinuous
buffer system as described by Laemmli.®^ A 3% stacking gel
overlay was used. At the completion of electrophoresis, gels were
fixed in methanolracetic acid:water (4:1:5), and stained for 10 min
at 60° with 0.1% Coomassie Brilliant Blue R-250 dissolved in
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ethanolracetic acidrwater (25:8:67). The gels were destained in
the ethanol:acetic acid:water solution and dried under vacuum.
The dried gels were subjected to autoradiography at -80°
using Kodak XAR-2 film with intensifying screens. Densitometric
scans of the autoradiograms were performed using a scanning densi¬
tometer (Model GS 300, Hoeffer Scientific, San Francisco, CA).
The following proteins (Bio-Rad Laboratories) were used as
molecular weight standards: myosin--200; ^-galatosidase--116;
phosphorylase B--92.5; bovine serum albumin--66; ovalbumin--45; and
yeast alcohol dehydrogenase--37 (Sigma). The molecular weights
were reported in kilodaltons (K).
Nondenaturing gels contained 7% acrylamide:bis acrylamide,
0.375 M Tris-HCl ( pH 8.9), 0.08% ammonium persulfate, and 0.08%
TEMED. A 3% stacking gel overlay was used. SDS was omitted from
the gel and from the electrophoresis buffer.
Preparation of Polyclonal Antibodies
To obtain antibodies directed against ribonucleotide reduc¬
tase, a rabbit was injected with a solution containing the doublet
protein (82-78 K) from the P. stutzeri protein fraction. The
doublet protein band was excised from preparative SDS-polyacryl-
amide gels and the protein was extracted from the gel by soaking
overnight in phosphate buffered saline (PBS). The protein was
concentrated by lyophilization and mixed in equal proportion with
Freund's adjuvant. Approximately 1 mg of doublet protein was
injected into the rabbit intramuscularly, and additional injections
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were administered following an appropriate immunization schedule.
The rabbit was bled and the serum fraction was collected and stored
at -70°. In some cases, an IgG fraction was obtained from the
serum by precipitation with an equal volume of 4 M ammonium sul¬
fate. The IgG fraction which precipitated was taken up in water
and dialyzed against PBS containing 0.1% sodium azide.
Ouchterlonv Double Diffusion and Immunoprecipitation
Ouchterlony double diffusion®^ was conducted on plates com¬
posed of 1% agarose containing 0.1% sodium azide in PBS. A pattern
of one center well and six surrounding wells was stamped into the
agarose. Ten /xl of antigen was placed in the center well and
serial dilutions of serum were placed in the outer wells. Following
2 or more days of incubation in a humidity chamber (a large Petri
dish with moistened filter paper), the plates were stained with
Coomassie Brilliant Blue R-250 in 2.5% perchloric acid. The anti¬
gens used were as described in the figure legend.
Double immunoprecipitation assays were performed as follows.
To samples containing 0.3 mg of solubilized protein fraction, 0.4
mM [^H]CTP, and 22 mM phosphate buffer (pH 7.3) was added 0.05 ml
of PBS containing 0-3 mg of either immune or nonimmune serum in a
total of volume of 0.2 ml. The samples were incubated for 1 hr at
10°, and 4 mg of goat anti-rabbit IgG in 0.15 ml PBS was added
slowly with constant stirring. Goat anti-rabbit IgG was produced
by personnel in the Endocrinology Laboratory at The Centers for
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Disease Control, Atlanta, GA. Following incubation for 10 min at
15°, the samples were kept overnignt at 4°. Samples were centri¬
fuged and the supernatants assayed for CTP reductase activity.
Western Blot Analysis
The enzyme-linked immunoelectrotransfer blot technique (EITB)
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was performed as described by Tsang et al. with modifications
as described by Bio-Rad. The protein fraction was separated by
electrophoresis on 7% SDS-polyacrylamide gels as described above.
The proteins were transferred to nitrocellulose sheets in the
Bio-Rad Trans-Blot cell overnight at 30 V and subsequently for 1 hr
at 60 V. Following washing of the nitrocellulose and blocking with
3% gelatin, the nitrocellulose sheet was incubated overnight with a
1:50 dilution of antiserum in antibody buffer (1% gelatin in TBS).
Following extensive washing the sheet was treated with goat anti-
rabbit IgG-horseradish peroxidase conjugate (Bio-Rad) and substrate
color reagent (Bio-Rad) as described by the supplier. Nitrocel¬
lulose sheets which were not treated with antiserum were stained
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with India ink as described by Hancock and Tsang. Pelican
Drawing Ink solution (3^1/ml) was prepared in PBS buffer contain¬
ing 0.15 M NaCl, 0.01 M NaPO^ (pH 7.2), and 0.3% Tween-20. After
staining overnight, the nitrocellulose sheet was rinsed with de¬
ionized water and photographed.
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Analysis of Kinetic Data
Data from kinetic experiments were analyzed using the PROPHET
computer system and the BINKIN2 program for kinetic data analysis
(PROPHET Software, NIH sponsored). Lineweaver-Burk plots were ob¬
tained by fit of the line calculated from and values
which were determined by iterative fit of a rectangular hyperbola
to the raw data using the Henri-Michaelis-Menton equation^® [v =
('^max ^ 5) / (l^m Other analyses were conducted as de¬
scribed in the "Results" section.
RESULTS
Isolation of the Ribonucleotide Reductase Activity
Preparation of the Ribonucleotide Reductase Protein Fraction
In previous studies conducted by Holt et al.^^»^^ the
ribonucleotide reductase activity in P. stutzeri cells was found to
be tightly associated with the bacterial membrane in a complex
which also contained phospholipids, RNA, 1 ipopolysaccharides, and
several other membrane-associated enzymes. The objectives of the
research described in this dissertation were to identify the poly¬
peptides comprising the ribonucleotide reductase protein in the
membrane-associated complex from P. stutzeri and to elucidate the
structural and kinetic properties of the enzyme.
The protein fraction which contained the ribonucleotide re¬
ductase activity was prepared by differential centrifugation of
cell extracts obtained by heat shock lysis of the cells following
lysozyme-EDTA treatment. Table 1 shows the results of the protein
preparation. The particulate fraction, P4, obtained after the
second high speed spin (130,000 x g) contained 75% of the ribo¬
nucleotide reductase activity, but only 13% of the total protein
when compared to the crude extract (Sj fraction). The specific
activity (reported as nmol dCTP/min/mg protein) of the P4 protein
fraction represented a 6-fold purification of the ribonucleotide
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Table 1. Preparation of Ribonucleotide Reductase Protein Fraction















S] -Supernatant'^ 185 24.4 4514 0.322 1454 100% 100%
Pp -Resuspended®
Pellet
180 8.0 1440 1.09 1570 32%^ 108%
S3 -Supernatants 172 12.5 2150 1.26 2709 47% 186%
P^ -Resuspended^ 12 49.2 590.4 1.85 1092 13% 75%
^Sixty grams of cells were suspended in 120 ml lysis buffer and
lysed by heat shock following lysozyme-EDTA treatment as de¬
scribed in the text.
^Specific activity reported as nmol dCTP/min/mg protein.
^Relative to the Sj supernatant.
‘^First low speed centrifugation (39,000 x g).
®First high speed centrifugation (100,000 x g).
^Low recovery possibly due to apparent low protein concentration.
9Second low speed centrifugation (39,000 x g).
*^Second high speed centrifugation (130,000 x g).
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reductase activity when compared with the specific activity of
the $1 fraction.
These results supported the findings of Holt et al.^^’^^
of the particulate nature of the protein fraction which contains
the ribonucleotide reductase activity in P. stutzeri cells.
SDS-Polyacrylamide Gel Electrophoresis of the Protein Fraction:
Polyacrylamide gel electrophoresis was employed in order to
elucidate the polypeptide composition of the protein fraction pre¬
pared by differential centrifugation of P. stutzeri cell extracts.
The complexity of the protein composition of the membrane-
associated fraction was demonstrated by SDS-PAGE analysis. Fig.
lA shows a 7% SDS polyacrylamide gel containing 60 /xg of the protein
preparation. Approximately 20 polypeptides ranging in size from
ca. 30-200 K were visible on the Coomassie blue stained gel.
Analysis of the protein fraction on a nondenaturing polyacrylamide
gel which contained no SDS yielded the pattern shown in Fig. IB.
A substantial portion of the protein remained at the top of the 7%
gel, however, most of the protein did not migrate through the 3%
stacking gel. The results from electrophoretic analysis indicated
that the fraction containing the ribonucleotide reductase had a









Figure 1. Electrophoretic analysis of the protein fraction. The
protein fraction obtained by differential centrifugation
was subjected to electrophoresis on 7% slab gels. A.
SDS-polyacrylamide gel; B. Nondenaturing polyacrylamide
gel. Lane lA - molecular weight markers, lanes IB and 2A
60 Mg of the protein fraction.
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Photoaffinitv Labeling Using Allosteric Site-Directed Probes
Photoaffinity Labeling With [^^P]dTTP:
One of the objectives of this research was to identify the
polypeptides in the membrane-associated protein fraction from P.
stutzeri that comprise the ribonucleotide reductase enzyme. Studies
by Eriksson et have demonstrated the usefulness of
deoxyribonucleotides as direct photoaffinity labels to probe the
allosteric binding site(s) of ribonucleotide reductase from mouse
and E. coli. In the following experiments [^^P]-labeled deoxy¬
ribonucleotides were used in an attempt to localize polypeptides in
the protein fraction from P. stutzeri which contain the ribonucleo¬
tide reductase allosteric binding site(s).
Samples containing the protein fraction were subjected to UV
irradiation for 60 min (or as indicated) in the presence of the
radioactively labeled deoxyribonucleotide. Samples were then
analyzed by SDS-PAGE and the radioactivity incorporated into the
polypeptides was determined by autoradiography of the gel.
Photoaffinity labeling of the protein fraction with
[^^PJdTTP resulted in incorporation of radioactivity into protein
which migrated in the SDS gel to a position corresponding to an
82-78 K doublet polypeptide (Fig. 28, arrow). Radioactivity was
also incorporated into material which remained at the upper part of
the gel where no Coomassie blue stained polypeptides were apparent
(Fig. 28, lanes 1 and 3). Incubation of the labeled protein in a
sample buffer which contained excess SDS (6.25%) instead of the
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Figure 2. Photoaffinity labeling with [^^PJdTTP. The protein
fraction was photolabeled with [^^PjdTTP (7.3 mM. 5
^iCi) by UV exposure for 1 hr as described in the text.
Following labeling samples were treated as follows;
lane 1 - no treatment, lane 2 - 0.25 M Tris-FICl (pFI 10)
for 10 min at 37°, lane 3 - sample buffer containing
6.25% SDS. A. Coomassie blue stained gel; B. Auto¬
radiogram.
32
sample buffer containing 1.25% SDS normally used for SDS-PAGE (see
"Methods") had no effect on the labeling by [^^P]dTTP (Fig. 2B,
lane 3). However, incubation of the [^^PJdTTP labeled protein
sample for 10 min at 37° in Tris-HCl (pH 10) prior to electro¬
phoresis reduced the radioactively labeled material which migrated
at the top of the gel, but did not affect incorporation of
[^^P]dTTP into the doublet polypeptide (Fig. 2B, lane 2). These
results demonstrated that labeling of the 82-78 K doublet polypep¬
tide by [^2p]dTTP was the result of a stable, covalent incorpora¬
tion of radioactivity into protein. Subsequent photoaffinity
labeling experiments, described below, revealed that only the 82 K
polypeptide of the doublet was labeled when [^^P]dTTP was used at
low concentrations (<10 mM).
In order to determine whether the incorporation of radioactive
dTTP into the doublet polypeptide was dependent on the time of UV
irradiation, a time course experiment was conducted. Aliquots of
the reaction mixture were removed after a given time of UV irradia¬
tion and the amount of radioactivity incorporated into protein was
determined. A plot of the radioactivity incorporated into total
acid precipitated protein as a function of irradiation time was
linear up to 60 min (Fig. 3A). An autoradiagram of the labeled
protein following SDS-PAGE showed that radioactivity was incor¬
porated into an 82 K polypeptide (Fig. 3B). A densitometric scan
of the autoradiogram shown in Fig. 3B indicated that the amount of
radioactivity incorporated into the 82 K polypeptide was directly
dependent upon the time of UV exposure (Fig. 3C).
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Irradiation Time (min.)
Figure 3A. Time course of [^^PJcITTP incorporation. A reaction mix¬
ture containing the protein fraction (84 Mg), 50 mM Tris-
HCl (pH 7.5), 5 mM DTT and 3mM (5.6 MCi) [32p]dTTP in
a volume of 120 /il was UV irradiated as described in the
text. An aliquot of 30 Ml was removed at the indicated
time points, added to TCA at a final concentration of 1%
and the pellet collected by centrifugation. The washed
pellet was suspended in 50 Ml SDS sample buffer. A 1 Ml
aliquot was counted in scintillation fluid to measure
radioactivity. Twenty m1 was subject to SDS-PA6E and
autoradiography. A. Plot of the radioactivity incor¬





Figure 3B and C. Time course of [^^P]dTTP incorporation. B. Auto¬
radiogram of a 7% SDS gel: lane 1 - 15 min, lane
2 - 30 min, lane 3 - 45 min, lane 4 - 60 min; C.
Densitometric scan of the 82 K band of the auto¬
radiogram.
35
Evidence for specific labeling of a deoxyribonucleotide bind¬
ing site by dTTP was obtained in competition experiments. A 100-
fold excess of a competing deoxyribonucleotide was added prior to
addition of [^^P]dTTP and UV exposure. Labeling of the 82 K
polypeptide was competed effectively by dGTP, dCTP, and dATP (Fig.
4, lanes 2-4), which are allosteric effectors of the ribonucleotide
reductase enzyme. The substrate, ATP, or substrate analog, azido-
ATP, did not inhibit labeling of the 82 K polypeptide by dTTP (Fig.
4, lanes 6 and 7). Specificity of the binding site for the triphos¬
phate form of the deoxyribonucleotide was suggested by the inabili¬
ty of the monophosphate, dTMP, to inhibit labeling by dTTP (Fig.
4, lane 5). Addition of DMBC, the cofactor for the P. stutzeri
ribonucleotide reductase, to the reaction mixture increased
[^^P]dTTP labeling of the 82 K polypeptide (Fig. 5). The in¬
crease was more than two-fold as determined by a densitometric scan
of the 82 K band labeled in the absence or presence of DMBC. The
samples used in this experiment were not treated with Tris-HCl (pH
10) prior to electrophoresis, hence the background is higher than
that observed in Fig. 4.
The results of the photoaffinity labeling experiments using
32
[ P]dTTP provided evidence that the 82 K polypeptide contained a
binding site specific for deoxyribonucleotides. These results also
strongly suggested that this site was an allosteric binding site of
the ribonucleotide reductase enzyme since (i) it was labeled by
dTTP, an allosteric effector of the enzyme, (ii) binding of dTTP










Figure 4. Competition of [^^P]dTTP labeling. Reaction mixtures
containing the protein fraction (1.4 mg/ml), 7.3
[^^PjdTTP (2.0 /iCi) and the indicated nucleotide (0.7
mM) were photolyzed for 60 min. Following photolysis,
0.25 M Tris-HCl (pH 10) was added and samples were incu¬
bated for 10 min at 37°. Sample buffer was added and
samples were analyzed by SDS-PAGE and autoradiography.
The autoradiogram of the gel is shown. Nucleotides added
were as follows: lane 1 - no addition, lane 2 - dGTP,
lane 3 - dCTP, lane 4 - dATP, lane 5 - dTMP, lane 6 -
azido-ATP, and lane 7 - ATP.
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Figure 5. Stimulation of [^^PJdTTP labeling by cofactor. Reaction
mixtures containing the protein fraction (1.4 mg/ml) and
7.3 /iM [^^P]dTTP (5 /iCi) were photolyzed for 60 min
as described in the text and analyzed by SDS-PAGE and
autoradiography. An autoradiogram (left) of the gel and a
scan (right) of the 82 K band are shown. Lane 1 - no
addition, lane 2 - 4 juM DMBC.
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(iii) the cofactor for the enzyme enhanced binding of dTTP at this
site.
Photoaffinity Labeling With [^^PJdGTP:
Photoaffinity labeling experiments were conducted using
[^^P]dGTP to further probe for binding sites for the allosteric
effectors of ribonucleotide reductase in the protein fraction. In
the absence of any other nucleotide, dGTP labeled several polypep¬
tides very faintly, including an 82-78 K doublet and polypeptides
with molecular weights of 68 K, 60 K, and 45 K {Fig. 6, lane 1).
Addition of DMBC to the reaction mixture increased dGTP labeling of
the 82-78 K doublet two-fold (Fig. 6, lane 2). Under the conditions
employed in this experiment, the combination of low binding and
high background prevented the measurement of an effect of addition
of a second deoxyribonucleotide on [^^P]dGTP labeling of the dou¬
blet (cfi Fig. 6, lane 3). Addition of 100-fold excess of substrates
increased dGTP labeling of the doublet up to 22-fold as compared
with the control containing no additional nucleotide. [3^P]dGTP
labeling of the doublet was enhanced 15-fold by ATP, 22-fold by
azido-ATP, and 12-fold by CTP (Fig. 6, lanes 4-6). These values
were obtained by measuring the area under the 82-78 K doublet peak
from a densitometer scan of the autoradiogram shown in Fig. 6.
These data are compiled in Table 2. UTP and GTP enhanced dGTP
labeling of the doublet at a level similiar to that of ATP (Fig. 7,
lanes 2 and 3). No observable effect on dGTP labeling of the dou¬
blet occurred in the presence of the nucleoside monophosphates,
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Figure 6. Photoaffinity labeling with [^^PJdGTP. Reaction mixtures
were as described in the text and contained 0.5
[^^P]dGTP (5/iCi) and 0.05 mM nucleotide as indicated.
Samples were photolyzed and analyzed by SDS-PAGE and
autoradiography. The autoradiogram is shown. Lane 1 -
no addition, lane 2 - 4 DMBC, lane 3 - dTTP, lane 4 -
ATP, lane 5 - azido-ATP, and lane 6 - CTP. The arrow
indicates the position of the 82 - 78 K doublet.
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1 None 0.6 1.0
2 DMBC 1.3 2.2
3 dTTP 0.8 1.3
4 ATP 9.1 15.0
5 Az-ATP 13.1 22.0
6 CTP 7.2 12.0
®Photoaffinity labeling was as described in the legend to Figure
6. Each lane of the autoradiogram was subjected to densitometric
scan. The area of the peak corresponding to the doublet protein was
calculated. ^^P incorporation (fold) was determined by comparing
the area of the doublet in the specified lane with the area of the
doublet in the control in lane 1 which contained no addition.
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Figure 7. Photoaffinity labeling with [^^P]dGTP. Reaction mixtures
were as described in the text and contained 1.0 juM
[^^P]dGTP (5 /iCi) and 0.1 mM nucleotide as indicated.
Lane 1 - 4 DMBC, lane 2 - DTP, lane 3 - GTP, lane 4 -
dGMP, and lane 5 - AMP. The arrow indicates the position
of the 82-78 K doublet.
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dGMP and AMP (Fig. 7, lanes 4 and 5). Nucleotide substrates and
deoxyribonucleotides enhanced [^^PJdGTP cleoside monophosphates,
dGMP and AMP (Fig. 7, lanes 4 and 5). labeling of a 60 K and a 45
K polypeptide. As discussed below, this labeling was determined to
be nonspecific.
The above results demonstrated that labeling of the 82-78 K
doublet polypeptides by dGTP was specifically enhanced by the co¬
factor and substrates of ribonucleotide reductase. Since only a
small amount of radioactivity was incorporated into the double
bands in the absence of substrates, the ability of the other deoxy¬
ribonucleotides to compete with dGTP labeling could not be demon¬
strated in direct competition experiments. To overcome this pro¬
blem, ATP (100-fold excess over [^^P]dGTP) was added to the
reaction mixtures to enhance labeling by [^^P]dGTP, and a 100-
fold excess of a nonradioactive deoxyribonucleotide was added prior
to UV exposure. Under these conditions, the enhanced [^^PJdGTP
labeling of the doublet induced by addition of ATP (Fig. 8, lane
1) was inhibited completely by excess nonradioactive dGTP and dATP
(Fig. 8, lanes 2 and 3). dTTP and dCTP reduced [^^P]dGTP label¬
ing of the doublet to 7% and 29% of the level observed in the
presence of ATP alone (Fig. 8, lanes 4 and 5). The areas of the
peak corresponding to the doublet polypeptides were calculated from
densitometric scans of the autoradiogram shown in Fig. 8. These
data have been quantitated in Table 3.
The results from this experiment demonstrated the specificity
of labeling of the 82-78 K doublet by [^^PJdGTP. Although several
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Figure 8. Competition of [^^P]dGTP labeling by deoxyribonucleo-
tides. Reaction mixtures were as described in the text
and contained 0.75 [^^P]dGTP (5 /iCi); 0.075 mM ATP,
4 /xM DMBC, and 0.075 mM deoxyribonucleotide as indicated.
Lane 1 - control ( no deoxyribonucleotide), lane 2 - dGTP,
lane 3 - dATP, lane 4 - dTTP, and lane 5 - dCTP. The
position of the doublet is indicated by the arrow.
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1 ATP 14.8 100.0
2 ATP + dGTP 0.1 0.7
3 ATP + dATP 0.1 0.7
4 ATP + dTTP 1.0 6.8
5 ATP + dCTP 4.2 29.0
®Photoaffinity labeling was as described in the legend to Figure
8. Each lane of the autoradiogram was subjected to densitometric
scan. The area of the peak corresponding to the doublet protein was
calculated. ^^P incorporation (percent) was determined as the
ratio of the area of the doublet in the lane indicated to the area
of the doublet in lane 1 which contained ATP.
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other polypeptides in the protein fraction were labeled, only
labeling of the doublet polypeptides was specifically stimulated by
substrates of ribonucleotide reductase and inhibited by deoxyribo-
nucleotide effectors of ribonucleotide reductase. The 60 K and 45
K polypeptides, which were also labeled by [^^P]dGTP, served as
controls to show that the observed inhibition and stimulation of
dGTP labeling of the doublet polypeptides were not the result of
generalized inhibition of the photolabeling reaction or experi¬
mental artifacts, but were due to photolabeling of specific sites
on the doublet polypeptides. While the doublet was not sufficiently
resolved to allow for independent quantitation of the 78 and 82
K polypeptides, it appeared that at the concentration used for
competition experiments, dTTP was capable of inhibiting dGTP binding
at both polypeptides of the doublet. The ability of dCTP to inhi¬
bit only 71% of the dGTP labeling of the doublet suggested that
binding of dCTP at these sites was weaker than binding of the other
deoxyribonucleotides or that dCTP was competing with dGTP labeling
at only one site.
The data obtained in experiments provided using [^^PjdGTP as
an allosteric site probe supporting evidence for inclusion of both
polypeptides of the doublet (82-78 K) as part of the ribonucleotide
reductase protein. The results suggested that dGTP labeling occur¬
red at allosteric binding sites of the enzyme since (i) labeling of
both polypeptides was enhanced by the cofactor, (ii) labeling was
competed by other deoxyribonucleotides, and (iii) labeling was
enhanced very significantly in the presence of substrates.
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Photoaffinity Labeling With [^^P]dCTP:
In an attempt to obtain supporting data for the assignment of
allosteric binding sites to the 82-78 K doublet polypeptides
and to determine whether dCTP binds to both polypeptides,
[^^P]dCTP was used as an allosteric site probe. Three polypep¬
tides with molecular weights of 82, 78, and 57 K were labeled by
dCTP (Fig. 9). The incorporation of radioactivity into protein
following labeling with dCTP was much less intense than labeling
obtained with dTTP. The low incorporation of radioactive dCTP into
the doublet supported the data from labeling experiments with
[^^P]dTTP and [^^PjdGTP in which dCTP was less effective at
competing labeling of the 78 and 82 K polypeptides. Substrates did
not enhance labeling of any of the polypeptides by [^^P]dCTP and
competition studies to determine the specificity of labeling by
dCTP were unsuccessful, partially due to the low level of incor¬
porated radioactivity which made it difficult to effectively deter¬
mine inhibition of labeling.
Labeling of the 82 K and the 78 K polypeptides by dCTP sup¬
ported the assignment of allosteric binding sites of the ribonu¬
cleotide reductase protein to these polypeptides. The significance
of labeling of the 57 K polypeptide by dCTP was unclear from this
experiment. One might speculate that dCTP was binding to a 57 K
polypeptide containing a substrate binding site and acting as a
product inhibitor in the back reaction. However, because reduction
of ribonucleotides is an irreversible reaction, no back reaction
MWxIO
47
Figure 9. Photoaffinity labeling with [^^PjdCTP. The reaction
mixture containing the protein fraction (1.4 mg/ml) and
0.2 /iM [^^P]dCTP (S.SpiCi) was photolyzed for 60 min
and subjected to SDS-PAGE and autoradiography. The auto¬
radiogram and a densitometric scan are shown. Arrows
indicate the 82-78 K doublet and 57 K polypeptides.
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would be expected and product inhibition should result only from
inhibition of deoxyribonucleotide binding at the allosteric
site(s).
Studies Using A Substrate Site-Directed Probe
Synthesis of 8-Azido-ATP:
In the experiments described in the preceeding sections,
[^^P]-labeled deoxyribonucleotides were used to identify the
allosteric binding sites of the ribonucleotide reductase enzyme
contained in the membrane-associated protein fraction from £.
stutzeri. In order to localize the substrate binding site of the
ribonucleotide reductase enzyme, 8-azido-ATP was selected as a
photoaffinity probe. Azido-ATP, an analog of ATP, has been suc¬
cessfully used by other researchers to label the ATP binding sites
of ATP utilizing proteins.
Nonradioactive 8-azido-ATP was synthesized for use in kinetic
studies to determine whether azido-ATP could interact with the
ribonucleotide reductase enzyme. The two-step procedure for syn¬
thesis of 8-azido-ATP is outlined in Fig. 10, and explained in de¬
tail under "Methods". In the first step, ATP was converted to
8-bromo-ATP by treatment with bromine-saturated water. The reaction
products were separated by chromatography on DEAE-Sephadex A-25 by
elution with a linear gradient of 0-1 M TEAS buffer. The elution




Figure 10. Synthesis of 8-azido-ATP. Step 1: ATP was treated with
bromine-saturated water for 16 hr at room temperature.
Step 2: The 8-bromo-ATP from step 1 was treated with tri¬
ethyl ammonium azide in DMF for 18 hr at 75°.
ABSORBANCE
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Figure 11. Elution profile of products from 8-bromo-ATP synthesis.
Sample (200 ml) was loaded onto a DEAE-Sephadex A-25
column (3.0 x 50 cm) and eluted with a linear gradient
(2.2 liters) of 0-1 M TEAB buffer (pH 7.5). Fractions
were collected in 9 ml and the absorbance at 254 nm was
measured by UV monitor.
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responding to each peak region were pooled and the sample was
characterized by its UV spectrum and relative mobility when ana¬
lyzed on PEI-cellulose by TLC. Peaks I and II were compounds with
Xmax values less than 232 nm. These compounds were probably
degradation products of the reaction (possibly 8-oxy-AXP®^).
Peaks III, IV, and V were identified as bromo-AMP, bromo-ADP, and
bromo-ATP, respectively, based upon their UV spectra and relative
mobilities on PEI-cellulose. These three peaks had a value
of 264 nm which is characteristic for the bromo-compound,®^ and
relative mobilities of 0.85, 0.7, and 0.58, respectively. The UV
spectrum of the purified 8-bromo-ATP is shown in Fig. 12. The
experimental yield of 8-bromo-ATP was 62% based upon 614 mg (1
mmol) of starting material {ATP[Na2 3H2O] Mp=610 mg/mmol),
and 552 mg (0.62 mmol) of product (8-Br-ATP[TEA]4 Mp=889
mg/mmol®^).
In the second step of the synthesis, 8-bromo-ATP was converted
to 8-azido-ATP by treatment with triethyl ammonium azide under anhy¬
drous conditions for 18 hr at 75°. The elution profile of the re¬
action products separated by chromatography on a DEAE-Sephadex A-25
column is shown in Fig. 13. Peaks I, III, and V contained azido-
AMP, azido-ADP, and azido-ATP, respectively. Peaks II and IV
contained bromo-ATP and bromo-ADP. The azido- and bromo- compounds
were distinguished by their different X^jg^ values (azido = 279 nm
and bromo = 264 nm at pH 7.5), and by the ability of the azido-
compounds to bind to cellulose plates when photolyzed.®^ The
azido-compounds were differentiated based upon their relative
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Figure 12. UV spectrum of S-bromo-ATP. The UV spectrum of 8-bromo-
ATP in TEAB buffer (pH 7.5) was recorded scanning from





Figure 13. Elution profile of products from 8-azido-ATP synthesis.
Sample (200 ml) was loaded onto a DEAE-Sephadex A-25
column (3.0 x 50 cm) and eluted with a linear gradient
(2 liters) of 0-1 M TEAS buffer (pH 7.5). Fractions were
collected in 10 ml and the absorbance at 279 nm was
measured manually.
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mobilities on PEI-cellulose TLC plates: azido-ATP = 0.15, azido-ADP
= 0.30, azido-AMP = 0.54. Fig. 14 shows the UV spectrum of the
azido-ATP prepared in this lab before and after photolysis for 10
min using a short wave lamp. The shift in the X ^lax spec¬
trum after photolysis is characteristic for the azido-group. The
yield of 8-azido-ATP from step 2 of the synthesis was ca. 26%,
based upon 0.5 mmol of starting material (8-Br-ATP[TEA]4 My.=889
mg/mmol) and 0.13 mmol of product (8-azido-ATP[TEA]4 My.=851
mg/mmol). The overall yield of azido-ATP from this synthesis was
16%.
Inhibition of ATP Reduction by Photolyzed 8-Azido-ATP:
Following the synthesis of nonradioactive 8-azido-ATP, experi¬
ments were designed to determine whether azido-ATP could interact
with the ribonucleotide reductase enzyme. In the first experiment,
a series of reaction mixtures that contained a fixed amount of
protein, buffer, MgS04, and increasing concentrations of azido-ATP
were subjected to photolysis. Following photolysis, the remaining
components required for the ATP reductase assay were added to the
photolyzed reaction mixtures and ATP reduction was measured.
Evidence to demonstrate that azido-ATP could interact with the
enzyme is presented in Figure 15. This figure shows the concentra¬
tion dependent inhibition of ATP reduction obtained by photolysis
of the enzyme preparation in the presence of increasing concentra¬
tions of azido-ATP. A concentration of 2.5 mM azido-ATP decreased
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Figure 14. UV spectrum of 8-azido-ATP. The UV spectrum of the sample
in water was recorded. The same sample was photolyzed
for 10 min at room temperature using a short wave UV lamp
and the UV spectrum was again recorded. The symbols on
the spectra were added to distinguish between the two
spectra. □ before photolysis, ^ after photolysis.
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Figure 15. Inhibition of ATP reduction by photolyzed 8-azido-ATP.
The reaction mixtures containing 0.04 M Bicine (pH 8.4),
5 mM MgS04, 1 mg protein, and azido-ATP as indicated
were photolyzed for 10 min on ice. Following photoly¬
sis, the remaining assay ingredients were added and ATP
reductase activity was measured. The activity remain¬
ing was reported as the percent of the activity in an
irradiated sample that contained no azido-ATP.
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the rate of reduction of ATP to ca. 20% of the control which was
photolyzed in the absence of azido-ATP. Fifty percent inhibition
was obtained with 1.0 mM azido-ATP. These results demonstrated
that azido-ATP was capable of interacting with the ribonucleotide
reductase enzyme at a site which inhibited reduction of ATP.
Inhibition of ATP Reduction by Unirradiated 8-Azido-ATP:
The previous experiment demonstrated the ability of azido-ATP
to inhibit ATP reduction. An additional experiment was designed in
an attempt to determine whether azido-ATP and ATP bind at the same
site. Analysis of inhibition patterns exhibited by substrate ana¬
logs and alternative substrates can allow one to draw some conclu¬
sions about the mechanism of an enzyme catalyzed reaction and the
number of substrate binding.sites on the enzyme. To determine the
type of inhibition of ribonucleotide reductase exhibited by azido-
ATP with respect to ATP reduction, saturation curves measuring ATP
reduction were constructed from assay series conducted in the ab¬
sence or presence of 0.5 mM azido-ATP. The reaction was carried
out in the dark to prevent photoactivation of the azido-group.
The mechanism for an enzyme catalyzed reaction involving
binding of substrate at one site in the absence of an inhibitor is
shown in Scheme 1. The corresponding equation, called the Henri-
Scheme 1:
ki kp
E + S - —- ES ——> E + P
k-1








observed velocity, S = the substrate concentration, =
= the maximum velocity, and K„ = k i/k, = the substrate
p t m -11
88
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The data from the inhibition of ATP reduction by azido-ATP are
shown in Fig. 16. The addition of azido-ATP caused the apparent
K„ for ATP reduction to increase from 0.13 mM to 0.30 mM. Them
Vjj^ax decreased slightly from 0.38 to 0.31. A pattern in
which the K„ is increased and the is unchanged is typical
for competitive inhibition. The mechanism for competitive inhibi¬
tion is shown in Scheme 2. Competitive inhibition results from
binding of the inhibitor to the enzyme such that binding of the
substrate is prevented.
Scheme 2:








Kmd + I/K^) + S
(2)
The resultant El complex is a dead-end complex which cannot bind
substrate to yield product. Inhibition results in a decrease in
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Figure 16. Inhibition of ATP reduction by unirradiated 8-azido-ATP.
ATP reduction was measured in assay mixtures containing
0-0.4 mM [^^C]ATP and other assay ingredients as described
in the text. ATP saturation curves were constructed from
assays conducted in the absence (□) and presence (O)
of 0.5 mM 8-azido-ATP. The data were analyzed on the
PROPHET computer system using the BINKIN2 program for
kinetic data analysis. A. Rectangular hyperbola fit to
observed data; B. Lineweaver-Burk double-reciprocal plot
fit to observed data.
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the amount of free enzyme available to bind substrate, hence an
increase in the K^,, while the is not changed. The presence
of a competitive inhibitor increases the by a factor of (1 +
I/K^) as shown in equation 2, where I = the inhibitor concentra¬
tion, and is the binding constant for binding of the inhibitor
to the enzyme. A clearer interpretation of the kinetic data can be
obtained if the data is plotted in a linear form. The equation for
a Lineweaver-Burk double-reciprocal plot of the data is shown below
in equation 3. Plotting the data from competitive inhibition in a
double-reciprocal plot gives a characteristic plot in which the
1/v = l/S(VV„ax)(l + lAi) + 1/V„ax (3)
lines intersect at the l/V^iax intercept on the y-axis. The
pattern of the double-reciprocal plot for inhibition of ATP reduc¬
tion by azido-ATP (Fig. 16B) was similar to that expected for
competitive inhibition, however, the slight change in the V^jax
caused the position of intersection of the lines to deviate some¬
what. Assuming competitive inhibition, the value of can be
calculated from the apparent observed in the presence of the
competitive inhibitor: K„,app = Kn,(l+I/K^). The for azido-ATP
binding was calculated as 0.4 mM.
The results obtained in this experiment demonstrated that
azido-ATP could bind to the substrate site of the ribonucleotide
reductase enzyme, and should, therefore, be useful as a substrate
site-directed probe.
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Photoaffinity Labeling with [^^P]8-Azido-ATP:
Commercially prepared [^2p]8-azido-ATP was used in photo¬
affinity labeling experiments in an attempt to localize the sub¬
strate binding site of the ribonucleotide reductase enzyme. The
protein fraction was subjected to UV irradiation for 10 min in the
presence of 30 /xM 8-azido-ATP. Analysis of the labeled protein
fraction by SDS-PAGE and autoradiography revealed that about 7
polypeptides contained radioactivity at various levels of intensity
(Fig. 17, lane 1). Specificity of labeling of these polypeptides
by azido-ATP was not demonstrated by competition with 100-fold
excess of any of the ribonucleotide triphosphate substrates. The
pattern of azido-ATP labeling in the presence of excess GTP, CTP,
or UTP was the same as was observed in the absence of any added
substrate (Fig. 17, lanes 2-4). Because of its position on the
edge of the slab gel, lane 4 exhibited a diminished overall level
of radioactivity incorporated. This is an apparent artifact
arising from distortion of bands in this lane.
In studies using [^^PJCDP to label the catalytic site of
mouse ribonucleotide reductase, Caras et al.®^ observed that
successful labeling of the Ml subunit of the enzyme required the
presence of ATP and the M2 subunit of the enzyme. In an attempt to
obtain specific labeling of the catalytic site of the P. stutzeri
enzyme, photolabeling with [^^P]8-azido-ATP was performed in the
presence of dGTP and DMBC, the allosteric activator and cofactor,






Figure 17. Photoaffinity labeling with [^^P]8-azido-ATP. Reaction
mixtures containing the protein fraction (1.4 mg/ml),
30 [^^P]8-azido-ATP (5 ^nd 0.3 mM nucleotide
(as indicated) were photolyzed for 10 min. Samples were
analyzed by SDS-PAGE and autoradiography. The autoradio¬
gram is shown. Lane 1 - no addition, lane 2 - GTP, lane
3 - CTP, and lane 4 - UTP.
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Figure 18. Competition of [^^P]8-azido-ATP labeling. Reaction
mixtures contained protein fraction (1.4 mg/ml), 30
[32p]8-azido-ATP (5 /iCi), 0.93 mM dGTP, 4 //M DMBC, and
0.3 mM nucleotide as indicated. Following photolysis for
10 min, samples were analyzed by SDS-PAGE and autoradio¬
graphy. Lane 1 - ATP, lane 2 - azido-ATP, lane 3 - no
addition, lane 4 - GTP, lane 5 - UTP, lane 6 - dATP, lane
7 - dCTP, lane 8 - dTTP, and lane 9 - CTP (6.3 mM). The
arrow indicates the position of the 57 K polypeptide.
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The labeling pattern with [^^P]8-azido-ATP observed when dGTP
and DMBC were added to the reaction mixture (lane 3) was the same
as was observed in the absence of these compounds (cf. Fig. 17,
lane 1). Addition of dGTP and DMBC did not increase the ability of
the nonradioactive nucleotide substrates to specifically inhibit
azido-ATP labeling of any of the polypeptides. ATP and nonradioac¬
tive azido-ATP did reduce the overall intensity of the radioacti¬
vity incorporated into polypeptides during labeling with [^^P]8-
azido-ATP (lanes 1 and 2), but labeling was not altered by the
addition of a 100-fold excess of either GTP, UTP, dATP, dCTP, or
dTTP (lanes 4-8). However, when the protein fraction was labeled
with [^2p]8-azido-ATP in the presence of dGTP, DMBC, and CTP, a 57
K polypeptide was intensely labeled (lane 9). Labeling of a 107 K
polypeptide was also stimulated. Enchanced labeling of the 57 K
and 107 K polypeptides by [^2p]8-azido-ATP was found to be depen¬
dent upon the presence of CTP at high concentrations (dGTP and DMBC
were not required). The amount of radioactivity incorporated into
these polypeptides was dependent upon the concentration of CTP
added to the reaction mixture, and enhanced labeling was only
observed at CTP concentrations greater than 5 mM (Fig. 19, lanes
1-6). The specific labeling of the 57 K and 107 K polypeptides by
azido-ATP in the presence of CTP suggested that these polypeptides
might contain substrate binding sites of the ribonucleotide reduc¬
tase enzyme. Direct evidence for assignment of substrate binding
sites was not obtained from this study since specificity for sub¬
strate binding was not established in competition experiments.
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Figure 19. CTP stimulation of [^2p]8-azido-ATP labeling. Reaction
mixtures containing SOpiM [^^P]8-azido-ATP (5MCi) and
additions as indicated, were photolyzed for 10 min. The
autoradiogram of the gel is shown. Lane 1 - no addition,
lane 2 - 1 mM CTP, lane 3 - 2.5 mM CTP, lane 4 - 5 mM CTP,
lane 5 - 10 mM CTP, and lane 6 - 20 mM CTP. The arrows
indicate the position of the 107 K and 57 K polypeptides.
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Kinetic Studies of Ribonucleotide Reduction
Effect of Alternative Substrates on Reduction of ATP:
In photoaffinity labeling studies, high concentrations of
CTP, an alternative substrate of ribonucleotide reductase, sti¬
mulated specific labeling of a 57 K and a 107 K polypeptide by the
substrate analog, azido-ATP. If CTP and azido-ATP were binding at
the same substrate site, then one might expect labeling by azido-
ATP to be inhibited in the presence of excess CTP. The observation
that excess CTP actually enhanced specific labeling of polypeptides
by azido-ATP suggested the possibility of multiple substrate
binding sites and cooperative substrate binding.
As discussed earlier, inhibition studies can be used to make
some predictions about the number of binding sites on an enzyme.
Kinetic studies using the alternative substrates of the P.
stutzeri ribonucleotide reductase enzyme were conducted in order
to determine whether CTP and the other alternative substrates (GTP
and UTP) were competitive inhibitors of ATP, and the results were
used to predict the number of possible substrate binding sites.
Substrate saturation curves were constructed by measuring ATP
reductase activity at variable ATP concentrations in the absence
and presence of 0.6 mM of each of the alternative substrates. The
results are shown in Fig. 20 and quantitated in Table 4. CTP, GTP,
and UTP increased the apparent K^ for ATP reduction but had no
substantial effect on the The results are consistent with
max
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Figure 20. _ Effect of alternative substrates on reduction of ATP. ATP
reduction was measured in assay mixtures containing 0.06
- 0.4 mM [^^C]ATP, 0.9 mM dGTP, and 0.6 mM nucleotide as
indicated. A. Hyperbolic curve fit to observed data; B.
Double-reciprocal plot fit to observed data. □ - None,
• - CTP, A - GTP, + - UTP.
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Table 4. Kinetic Parameters for Inhibition of ATP Reduction by
Alternative Substrates^
Addition to
Assay Series ^m '^max
Inhibition
(Apparent)
Control none 0.12 0.87 —
CTP 0.37 0.81 competitive
GTP 0.22 0.92 competitive
UTP 0.18 0.89 competitive
^Values calculated from graphs in Figure 20.
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competitive inhibition as presented in Scheme 2 and equation 2.
The lines of the double-reciprocal plot of the data (Fig. 20B)
also gave the pattern of intersection at the y-axis which is
characteristic for competitive inhibition (equation 3). The
values calculated from the apparent in the presence of the
inhibitors were 0.3 mM, 0.8 mM, and 1.2 mM for CTP, 6TP, and UTP,
respectively.
The apparent competitive inhibition of ATP reduction by the
alternative substrates of ribonucleotide reductase suggested that
all of the substrates bind at a common site on the enzyme.
However, as was observed with the substrate analog, azido-ATP, the
alternative substrates caused a slight change in the of
ATP reduction. This suggested a more complex interaction of
substrates with the enzyme than that which occurs in pure competi¬
tive inhibition.
If an alternative substrate were a true competitive inhibitor
of ATP reduction, then according to the expression for competitive
inhibition in Scheme 2, the velocity of the reaction could be
driven to zero at a very high concentration of inhibitor. At such
a high concentration of the inhibitor, all of the enzyme would be
tied up in the dead-end El complex, and the velocity of the
reaction would be zero. To test whether the velocity of ATP
reduction could be driven to zero at a very high concentration of
CTP, the velocity of ATP reduction was measured at a fixed concen¬
tration of ATP (0.4 mM) while the CTP concentration was increased
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from 0 to 10 mM. The percent inhibition expected at any given
concentration of a competitive inhibitor can be calculated from
equation 4, where i = fractional inhibition (lOOi = percent inhibi¬
tion).®® The concentration of a competitive inhibitor required
for 50% inhibition is given by equation 5.®® Using these two
equations and the K„, for ATP (0.012 mM) and the for CTP (0.3
mM) from the previous experiment, the concentration of CTP required
for 50% inhibition was calculated at 1.3 mM. Ten mM CTP should give
89% inhibition of ATP reduction.
i = 1/[I + Ki (1 + S/K^)]
l0.5 = (1 + VKJ Ki
The results of this attempt to drive the velocity of ATP re¬
duction to zero by increasing the CTP concentration are shown in
Fig. 21. The rate of ATP reduction at 1.3 mM CTP was ca. 75% of
the control (no CTP), with only 25% inhibition observed instead of
the 50% inhibition predicted by equation 5. At 10 mM CTP the
velocity of ATP reduction was about 45% of the control instead of
the 89% predicted by equation 4.
The results from this experiment showed that the velocity of
ATP reduction was not driven to zero at the concentration of CTP
which should have resulted in nearly complete inhibition if CTP
were a true competitive inhibitor. These results showed that a





Figure 21. Effect of variable [CTP] on reduction of ATP. ATP reduc¬
tion was measured in assay mixtures containing 0.4 mM
[1^C]ATP, 0 - 10 mM CTP, and 0.9 mM dGTP.
flCTIUITYREMfllMING
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was not adequate to explain the pattern of apparent competitive
inhibition of ATP reduction observed in the presence of the alter¬
native substrates. The data from this study and the previous one
which showed apparent competitive inhibition could however be
accomodated by a two-site mechanism involving partial competitive
inhibition. The expression is outlined in Scheme 3.
Scheme 3:
Kc








El + S ^ ESI—- El + P
In partial competitive inhibition, two separate sites exist on
the enzyme for the binding of the substrate and the inhibitor.
Hence, the substrate can bind to either free enzyme or to the El
complex to form product {unlike the situation that exists in true
single-site competitive inhibition, where the El complex has no
affinity for binding of S). The El complex has a decreased affini¬
ty for binding substrate when compared with the free enzyme. As a
result, in the presence of a partial competitive inhibitor, the
apparent K^, for substrate binding to the El complex is increased by
a factor, a . The is unchanged. The equation for partial






Ks (1 + I/Ki)/(1 + I/aK^) (6)
high (saturating) inhibitor concentration equation 6 reduces to
equation 7, indicating that all of the available enzyme is in the
El complex with its decreased affinity for substrate binding. The
apparent Kg is equal to aKg, the binding constant for substrate to
El.
aKg + S
Inhibition of only 45% of the ATP reduction in the presence of
10 mM CTP suggested that CTP acted as a partial competitive inhibi¬
tor of ATP. Using equation 7 the a factor for CTP inhibition of ATP
reduction was calculated at 8.5. In terms of the mechanism in
Scheme 3, the enzyme with the CTP binding site saturated had an
affinity for ATP binding which was 8.5 times lower than the affini¬
ty of the free enzyme for ATP. These results provided evidence
that CTP is not a true competitive inhibitor of ATP, but rather
acts as a partial competitive inhibitor. Partial competitive
inhibition can be explained by a two site model for binding of the
substrate and the inhibitor. The results, therefore suggested that
two sites could be present on the enzyme at which substrates of the
enzyme can bind. From this experiment it was not clear whether
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both ATP and CTP can bind at each site, however, the model in its
simplest form (Scheme 3) indicates that one site is unique for
binding of the substrate (ATP) and the other for binding of the
inhibitor (CTP).
In the presence of either a true competitive inhibitor or a
partial competitive inhibitor, the apparent values will be in¬
creased, while the will remain unchanged. The double¬
reciprocal form of equation 6 which describes partial competitive
inhibition is shown in equation 8. A comparison of equation 8 with
1/'' = VV^ax + I/aK.)] 1/S + (8)
the double-reciprocal form of the velocity equation for competitive
inhibition (equation 3) shows that in both partial competitive and
pure competitive inhibition, the slope of the curve obtained in the
presence of an inhibitor will be changed when compared with the
control containing no inhibitor (slope = K^/V_-^). As a result,
the double-reciprocal plot of the data obtained in experiments
using only one concentration of inhibitor will be identical for
both types of inhibition.
A distinction between pure competitive inhibition and partial
competitive inhibition can be made if the saturation curves are
constructed using several fixed concentrations of the inhibitor.
From equation 3 one finds that the slope of the double-reciprocal
plot is altered by the term (1 + I/K.), which means that as
the concentration of inhibitor is increased, the slope of the
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corresponding line representing a given inhibitor concentration
will also increase. Lines of the double-reciprocal plot construct¬
ed from data obtained at several fixed [I] will pivot counterclock¬
wise about the point of intersection with the control line
containing no [I] 1/v-axis) as [I] is increased.
If [I] is a pure competitive inhibitor the velocity at the limiting
(very high) [I] will be zero, therefore the line containing data
obtained at the limiting [I] will have a slope of zero and will be
vertical to the 1/v-axis. A replot of slope ys [I] for a pure
competitive inhibitor will be linear.
The slope of the line of a double-reciprocal plot of data ob¬
tained in the presence of a partial competitive inhibitor will also
be changed, but by a factor of (1 + I/K^)/(l + 1/ aK^) as indi¬
cated in equation 8. The lines of the double-reciprocal plot of
data obtained at several fixed concentrations of a partial competi¬
tive inhibitor will also pivot counterclockwise about a point of
intersection with the control curve. However, since the velocity
of the reaction in the presence of a partial competitive inhibitor
will not be driven to zero at the limiting concentration of [I],
the slope of the line will not reach zero, and the line will not be
vertical to the 1/v-axis. A plot of slope ys [I] for partial
competitive inhibitor will be nonlinear.
In order to confirm that CTP acted as a partial competitive
inhibitor of ATP reduction by the P. stutzeri ribonucleotide reduc¬
tase enzyme, saturation curves measuring ATP reduction at several
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fixed concentrations of CTP were constructed and the pattern of the
resulting double-reciprocal plot was analyzed. ATP reduction was
measured in assay series which contained either 0, 0.3, 0.6, 0.9,
or 10 mM (limiting) CTP. The results are shown in Fig. 22 and
quantitated in Table 5. As the concentration of CTP was increased,
the lines of the double-reciprocal plot pivoted counterclockwise
about the point of intersection with the control at the 1/v-axis.
The line corresponding to the limiting inhibitor concentration (10
mM CTP) was not vertical to the 1/v-axis. A replot of the slope ys
CTP concentration yielded a parabolic curve (Fig. 22B). Replots
of this type can be described by the expression. Slope = a(l + bl +
cl^), and result from binding of at least two inhibitor molecules to
the enzyme.®® The results from this experiment are in agreement
with those predicted for two-site partial competitive inhibition as
described in Scheme 3 and equations 6-8. While the data confirmed
CTP as a partial competitive inhibitor of ATP reduction, the para¬
bolic replot suggested a model in which two molecules of CTP were
involved in substrate binding. This result raised the possibility
that CTP was competing with ATP binding at two substrate binding
sites.
Effect of Alternative Substrates and Their Effectors on ATP Reduc¬
tion:
The demonstration that CTP acted as a partial competitive inhi¬















Figure 22. Effect of various fixed concentrations of CTP on reduc¬
tion of ATP. ATP saturation curves were constructed from
assay mixtures containing 0.06-0.6 mM [^^C]ATP, 0.9
mM dGTP, and CTP as indicated. A. Double-reciprocal
plot fit to calculated and Slope Replot.
^ - No CTP, ■ - 0.3 mM CTP, A - 0.6 mM CTP,
• - 0.9 mM CTP, #- 10 mM CTP.
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Table 5. Kinetic Parameters for Inhibition of ATP Reduction by
CTP®
Addition to
Assay Series *^m '^max Slope
Control none 0.083 0.538 0.183
0.3 mM CTP 0.142 0.523 0.264
0.6 mM CTP 0.219 0.464 0.425
0.9 mM CTP 0.335 0.484 0.597
10.0 mM CTP 0.713 0.440 1.69
^Values obtained from hyperbolic curve fit to observed data in
Figure 22A.
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ribonucleotide reductase enzyme for ATP (Kp^) was altered by a
factor a (calculated at 8.5 from equation 7) when CTP was bound to
the enzyme. The reduction of each of the four alternative sub¬
strates of ribonucleotide reductase (ATP, CTP, GTP, and UTP) is
activated by a specific deoxyribonucleotide effector, presumably by
induction of conformational changes in the enzyme which favor cat¬
alysis of the specific substrate. Since dATP, the product of ATP
reduction, is also the allosteric effector for CTP reduction, the
production of dATP during the course of the reaction could have
resulted in alteration of the enzyme's conformation to favor CTP
reduction. In such a case, some competition of ATP binding by CTP
at the catalytic site would be expected to occur. Competition of
ATP reduction by CTP binding at a noncatalytic site and at a cat¬
alytic site in the presence of dATP could then explain the observed
parabolic replot obtained in Fig. 22.
The following experiment was designed in order to detect any
change in the pattern of inhibition of ATP by the alternative
substrates when the allosteric effector for each of the alternative
substrate was added. ATP reduction was measured in assay series
that contained either CTP and dATP, GTP and dTTP, or UTP and dATP.
The control series contained only ATP and dGTP, and dGTP was pre¬
sent in each assay series. The results are shown in Fig. 23 and
quantitated in Table 6. Measurement of ATP reduction in the pre¬
sence of either of the alternative substrates and its allosteric
effector showed an increase in the apparent and a decrease in
the apparent ^^P reduction. When either GTP and dTTP
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Figure 23. Effect of alternative substrates and their effectors on
reduction of ATP. ATP saturation curves were constructed
from assay mixtures containing 0.06-0.6 mM [^^C]ATP,
0.9 mM dGTP, and nucleotides as indicated. Concentrations
used were; CTP, UTP, and GTP (0.6 mM); dATP (0.2 mM); and
dTTP (0.3 mM). A. Hyperbolic curve fit to observed data;
B. Double-reciprocal plot fit to calculated and
Vulax- ■ - No addition, 0 - CTP + dATP, ^ - GTP +
dTTP, ▼ - UTP + dATP.
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Table 6. Kinetic Parameters for Inhibition of ATP Reduction by






Control none 0.10 0.70 —
CTP + dATP 0.17 0.34 mixed-type
GTP + dTTP 0.19 0.58 mixed-type
UTP + dATP 0.20 0.55 mixed-type
^Values obtained from the data in Figure 23.
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or UTP and dATP were added, the apparent increased ca. 2-fold
and the apparent decreased ca. 20%. Addition of CTP and
dATP increased the apparent ca. 2-fold, and decreased the
apparent ca. 50%. The change in both the K^, and the
Vjnax resulted from mixed-type inhibition, and can not be accom¬
modated by either pure competitive (Scheme 2) or partial competi¬
tive (Scheme 3) inhibition.
Since both the alternative substrate and the alternative
allosteric effector were present, the observed mixed-type inhibi¬
tion could have resulted from competition of ATP at the substrate
site and dGTP at the allosteric site. The data in Fig. 21 showed
that very high concentrations of CTP did not drive ATP reduction to
zero. One might hypothesize that addition of dATP to the reaction
mixture would result in total inhibition of ATP reduction if the
observed mixed-type inhibition (Fig. 23) resulted from competition
at the substrate and the allosteric sites. To test this hypothesis,
ATP reduction was measured in assay series which contained fixed
concentrations of ATP (0.4 mM), dGTP (0.9 mM), and dATP (0.2 mM),
and CTP concentrations ranging from 0 to 20 mM. As shown in Fig.
24, the velocity of ATP reduction decreased sharply to ca. 50% of
the control as the CTP concentration was increased from 0 to 1 mM.
As the CTP concentration was further increased, the inhibitory
effect on ATP reduction was diminished, and at 20 mM CTP 25% of the
activity for ATP reduction remained. A comparison of the data in
Fig. 21 and Fig. 23 revealed that 10 mM CTP plus dATP inhibited
Buj/uiuj/diyp
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Figure 24. Effect of variable CTP plus dATP on ATP reduction. ATP
reduction was measured in assay mixtures containing 0.4




only 15% more of the ATP reduction than 10 mM CTP alone. This re¬
sult showed that the presence of a specific allosteric effector
enhanced the ability of substrates to compete for the catalytic
site, but that even at an extreme excess of one substrate, total
exclusion of the other substrate at the catalytic site did not
occur. The results therefore suggested that multiple catalytic sites
exist on the enzyme and that the observed mixed-type inhibition
could result from competition of ATP binding at these sites.
A mechanism for mixed-type inhibition is shown in Scheme 4.
This mechanism describes hyperbolic (partial) mixed-type
Scheme 4: E + S
+





El + S ^=^ESI > El + P
inhibition. By comparing Scheme 4 with Scheme 3 for partial com¬
petitive inhibition one finds that both mechanisms involve two
binding sites and are identical except that in hyperbolic mixed-
type inhibition the rate constant, kp, is multiplied by a factor.
The /3 factor describes the change in the rate constant in the
presence of the inhibitor, and has a value less than 1 for hyper¬
bolic mixed-type inhibition. Since = kpE^ (equation 1),
the /3 factor describes the decrease in the apparent V^g^ obtained
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in the presence of the inhibitor. The a factor describes the change
in the for substrate binding in the presence of the inhibitor.
The double reciprocal form of the velocity equation for hyper¬
bolic mixed-type inhibition is given by equation 9. Both the
1/v = Kg/V^igxCl+^Ai (slope))^/^
(int))
slope and the 1/v-axis intercept are altered in the presence of a
hyperbolic mixed-type inhibitor. The lines of the double-reci¬
procal plot intersect at a point to the left of the 1/v-axis and
above the 1/S axis, as was observed for inhibition of ATP reduction
by the alternative substrates in the presence of their allosteric
effectors (Fig. 23). Replots of slope ys [I] and 1/v-axis intercept
ys [I] are hyperbolic and are characteristic for mechanisms involv¬
ing hyperbolic mixed-type inhibition.®®
The following experiment was designed to test whether the
inhibition of ATP reduction which occurred in the presence of CTP
and dATP fit the mechanism for hyperbolic mixed-type inhibition
(Scheme 4). ATP saturation curves were constructed at several
concentrations of CTP (0.3, 0.6, 0.9, and 10 mM) at fixed concen¬
trations of dATP (0.2 mM) and dGTP (0.9 mM). The data were plotted
as the double-reciprocal plot and the slope and 1/v-axis intercept
for each line were measured. The slope and intercept replots were
constructed.
The results are shown in Fig. 25 and quantitated in Table 7.










Figure 25. Effect of various fixed concentrations of CTP plus dATP
on reduction of ATP. ATP reduction was measured in assay
series containing 0.06 - 0.6 mM [^^C]ATP, 0.9 mM dGTP,
0.2 mM dATP, and CTP as indicated. A. Double-reciprocal
plot fit to calculated and B ’ No CTP, Q-
0.3 mM CTP, A - 0.6 mM CTP, #- 0.9 mM CTP, □ - 10.0
mM CTP. B. Slope and 1/v-axis intercept replots:
O- slope, □ - 1/v-axis intercept.
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Table 7. Kinetic Parameters for Inhibition of ATP Reduction by
CTP in the Presence of dATP^
Addition to
Assay Series *^m ^max Slope Intercept
Control none 0.119 0.538 0.315 1.43
0.3 mM CTP 0.163 0.441 0.409 2.09
0.6 mM CTP 0.182 0.240 0.573 5.06
0.9 mM CTP 0.202 0.172 1.44 4.63
10 mM CTP 0.672 0.407 1.82 1.91
^Values were obtained from hyperbolic plots of data in Figure 25.
dATP (0.2 mM) was added to each series including the control.
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of the double-reciprocal plot appeared to intersect at a common
point to the left of the 1/v-axis and above the 1/S-axis as is
expected for mixed-type inhibition (equation 9). However, at 10 mM
CTP, the line intersected with the control very close to the 1/v-
axis as occurs in competitive (or partial competitive) inhibition.
Replots of the slopes and 1/v-axis intercepts obtained from the
double-reciprocal plot were nonlinear (Fig. 25B). At the low
[CTP] the replots were parabolic as was observed for CTP in the
absence of dATP (Fig. 22). The parabolic curve indicated binding of
two CTP molecules to the enzyme,At high [CTP] the replots
deviated from the parabolic curve. These results demonstrated that
while the two site model outlined in Scheme 4 for hyperbolic mixed-
type inhibition was suitable to describe the data at low [CTP], at
high [CTP] this model was not adequate. Therefore, a more complex
model for the binding of substrates to the ribonucleotide reductase
enzyme was indicated.
Substrate Inhibition:
Data from the previous experiments showed that in the absence
of their allosteric effectors, the alternative substrates acted as
partial competitive inhibitors of ATP reduction, but when their
allosteric effectors were added, the alternative substrates (at low
concentration) acted as hyperbolic mixed-type inhibitors of ATP
reduction. Analysis of the data from the previous experiments in
terms of the models for partial competitive (Scheme 3) and
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mixed-type (Scheme 4) inhibition indicated that the two-site model
with separate binding sites for ATP and the alternative substrate
was an inadequate model to describe this system. In addition, as
the concentration of ATP was increased beyond 0.6 mM, some sub¬
strate inhibition in the control curves was noted (c.f. Fig. 23),
indicating the possibility of multiple ATP binding sites.
An alternative model that could accommodate the observed inhi¬
bition patterns would be one in which two substrate binding sites
exist on the enzyme and the substrate and alternative substrate
could each bind at both sites. Such a model is described in Scheme
5. This two-site model assumes that both sites are catalytic sites
Scheme 5:

















and that binding of substrates at either site can lead to product
formation. The kinetic equation for this mechanism as derived by
Freiden^® using the rapid equilibrium method reveals that sub¬
strate inhibition should occur if the rate at which the SES complex
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breaks down to form product (k5) is slower than the rate at which
either the ES complex or the SE complex breaks down to product (k5
or k5/); that is, when k5/k5 < 1. It is also possible that one
would observe negative cooperativity of substrate binding if the
affinity of binding of the substrate at one site is decreased when
the other substrate binding site is occupied by substrate (i.e.
K3 or K4 > Kj or K2). Mixed-type inhibition could therefore be
accommodated using the two-site mechanism in Scheme 5, since in
mixed-type inhibition both the binding of substrate (K,„), and the
rate of product formation altered in the presence of
the inhibitor.
The mechanism in Scheme 5 predicts substrate inhibition in the
case where differences in either binding or catalysis at the two
substrate sites exist. Results from photoaffinity labeling (Fig.
19) and kinetic studies (Fig. 23) indicated the importance of high
alternative substrate concentration on the results obtained. In
order to determine whether substrate inhibition occurred at high
ATP concentrations, an ATP saturation curve was constructed by
varying the ATP concentration from 0 to 2.5 mM. The results of
that experiment are shown in Fig. 26. At low ATP concentrations
(0 to 0.6 mM) the data fit the Henri-Michaelis-Menton type hyperbo¬
lic saturation curve which describes an enzyme with one substrate
site (Scheme 1 and equation 1). However, as the concentration of
ATP was increased from 0.6 mM to 2.5 mM, marked substrate inhibi¬
















Figure 26. ATP saturation curve. ATP reduction was measured
in assays containing 0.05-2.5 mM [^^C]ATP, and 0.9
mM dGTP. A. Plot of velocity ys ATP concentration; B.
Double-reciprocal plot.
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non-linear and curved upward as the concentration of ATP was increased
{Fig. 26B). Extrapolation of the linear parts of the curve to the
1/v-axis allowed for calculation of the values of at low
and high ATP concentrations (see treatment of Fig. 26B). Since
V^ax directly proportional to the rate constant (kp), the
values for k5 and k5 in Scheme 6 could be calculated. From Fig.
26B, the value of k5 was calculated at 0.83 nmol dATP/m in/mg and
k5 at 0.43 nmol dATP/min/mg. The ratio of k5/k5 was 0.52 and
was less than 1 as predicted for substrate inhibition.^®
Since inhibition studies of ATP reduction done using CTP
as the alternative substrate indicated two binding sites for CTP,
it was of interest to determine whether CTP also exhibited sub¬
strate inhibition. Fig. 27 shows the substrate saturation curve
for CTP concentrations ranging from 0 to 2 mM. Substrate inhibition
was observed at CTP concentrations above 0.2 mM. Extrapolation of
the linear parts of the double-reciprocal plot of the data yeilded
values of 1.5 nmol dCTP/min/mg and 0.48 nmol dCTP/min/mg for k5
and k5, respectively (Fig. 27B). The value of k5/k5 was 0.32.
As was determined for ATP, the ratio of k5/k5 was less than 1
which indicated substrate inhibition.
The result from this experiment confirmed that at least two
substrate sites existed on the enzyme, and that ATP and CTP could
each bind at both sites. The results further showed that the
presence of the substrate on the second site lowered the velocity
of the reduction reaction, resulting in substrate inhibition. The
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Figure 27. CTP saturation curve. CTP reduction was measured in
assays containing 0.05 - 2.0 mM [^H]CTP and 0.15 mM
dATP. A. Plot of velocity ys CTP concentration; B.
Double reciprocal plot. O - low CTP, - high
CTP.
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change in kp which occurred when one of the substrate binding
sites was occupied indicated that the two substrate binding sites
were not independent, noninteracting sites, but rather that the two
sites exhibited negative cooperativity.^^ Negative cooperativity
occurs when binding of substrate at one site alters the conforma¬
tion such that either binding of the second substrate molecule, or
catalysis, is decreased. This experiment demonstrated that the
negative cooperativity resulted in a decrease in the rate of cat¬
alysis by the enzyme when both substrate sites were occupied.
In photoaffinity labeling studies it was observed that very
high concentrations of CTP induced binding of [^^P]8-azido-ATP at
a putative substrate binding site on the ribonucleotide reductase
enzyme. Since the induced labeling was only observed at very high
CTP concentrations, this suggested that at these high concentra¬
tions, CTP was binding at a site at which it acted to lower the
for 8-azido-ATP binding. This apparent positive cooperativity of
substrate binding was in opposition to the apparent negative
cooperativity of catalysis observed in the substrate saturation
experiments. However, in experiments showing induced photolabeling
of the 57 K polypeptide by 8-azido-ATP the effect was only observed
when CTP was present at concentrations greater than 5 mM. The
substrate concentration range used in the saturation experiments
did not exceed 2.5 mM. Therefore, by constructing the ATP satura¬
tion curve over a very wide range of ATP concentrations, one should
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be able to determine whether very high substrate concentrations
result in positive cooperative effects.
ATP reduction was measured at ATP concentrations varying from
0.06 to 20 mM. The results (Fig. 28) showed that the velocity of
ATP reduction increased hyperbolically as the ATP concentration was
increased from 0.06 to 0.6 mM as is expected for normal Michaelis-
Menton saturation kinetics. As the ATP concentration was increased
from 0.6 to 2.5 mM substrate inhibition occurred as was previously
observed (Fig. 26). At ATP concentrations above 3 mM, however, the
velocity of ATP reduction increased dramatically up to 6 mM, where
it essentially reached a plateau. An essentially identical pattern
was observed when the CTP saturation curve was constructed varying
the CTP concentration from 0.06 to 20 mM (Fig. 29). For CTP
saturation, substrate inhibition was observed from 0.2 to 2 mM CTP.
The velocity rose sharply as the CTP concentration was increased
beyond 2 mM, and reached a plateau at about 6 mM.
The pattern observed in the substrate saturation curves demon¬
strated that a complex set of both negative and positive coopera¬
tive interactions was occurring in this system. Koshland and his
colleagues®^observed a similar type of "bumpy" substrate
saturation curve for CTP synthase from E. coli with glutamine as
the substrate. In those studies, the saturation curve, which
contained two points of inflection as does the ATP and CTP satura¬
tion curves in this study, was described as undergoing a transition
from hyperbolic at low substrate concentrations to sigmoidal at
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Figure 28. ATP saturation over a wide range of ATP concentrations.
ATP reduction was measured in assay series containing
0.05-20 mM [1^C]ATP and 0.9 mM dGTP. The computer
simulated curve was fit to the observed data using
Equation 10 as described under "Results".
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Figure 29. CTP saturation over a wide range of CTP concentrations.
CTP reduction was measured in assay series containing
0.05-20 mM [^H]CTP and 0.15 mM dATP. The computer
simulated curve was fit to the observed data using Equa¬
tion 10 as described under "Results".
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high substrate concentrations. Koshland's analysis of the satura¬
tion curve for the E. coli CTP synthase, which has four equivalent
substrate binding sites and is allosterically regulated by 6TP,
demonstrated that a bumpy saturation curve could be generated only
if at least two of the substrate sites exhibited ligand induced
negative cooperativity (i.e. if K'i>K'2<K'3 where K'j, K'2>
and K'3 are the intrinsic binding constants for substrate sites 1,
2, and 3). From this rapid equilibrium analysis of the data,
Koshland predicted that in order to generate "bumpy" substrate
saturation curves, at least 3 substrate binding sites must be
present on the enzyme.®^
The equations developed in Koshland's analysis were based on
the rapid equilibrium assumption in which it was assumed that the
rates of equlibrium between substrate and enzyme were rapid rela¬
tive to the rates of catalysis. Applying Koshland's analysis to
our system would imply that at least three substrate binding sites
exist on the ribonucleotide reductase enzyme for binding of ATP or
for binding of CTP. In the absence of detailed structural informa¬
tion about this enzyme, however, it is possible that rapid equili¬
brium conditions do not exist and that the rate of binding of
substrate to the enzyme is of the same magnitude as the rate of
catalysis, i.e. that a steady state between binding and catalysis
exists.
Applying the steady-state treatment to the derivation of a
rate equation for the two-site model described in Scheme 5 resulted
in an equation with the general form of a quadratic. A simplified
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form of the steady-state equation for a two-site model containing
two nonidentical sites is given by equation 10, where y = v, x =
[S], and a^>=0 and where the a^ parameters describe complex combi¬
nations of binding and rate constants.*
ajx + a2X^ + a3X^
y = (10)
1 + a4X + 35x2 + a5X^
To test this model for our system, equation 10 was used as a
function and a computer generated fit of the function to the ex¬
perimental data for the ATP and CTP saturation curves was attempt¬
ed. The curves in Fig. 28 (ATP) and Fig. 29 (CTP) are the results
of the computer generated fit using equation 10. Although an
apparent good fit was obtained, negative values for some of the
parameters (33 and 35) were obtained. Since negative values for
binding and rate constants have no real significance in a physio¬
logical system, the results suggested that equation 10 derived from
the two-site model in Scheme 5 was not adequate to describe the
ribonucleotide reductase enzyme. A higher order quadratic equation
was indicated, which suggested that a model with more than two
substrate binding sites was necessary. It should be pointed out
that a more thorough analysis of the data obtained from curve
fitting would be required before this model could be totally eli¬
minated. In addition, calculations done on the amount of substrate
*Dr. Frank E. Cummings, personal communication.
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converted to product showed that at low substrate concentrations a
significant portion of the substrate was converted to product.
This could affect a correct interpretation of the substrate satura¬
tion curves since the concentration of available substrate is alter¬
ed during the course of the reaction. These studies should,
therefore be repeated taking these points into consideration.
Analysis of the data obtained in inhibition studies has re¬
sulted in elimination of several models for the binding of sub¬
strates to the ribonucleotide reductase enzyme. The observation of
partial competitive inhibition in analysis using alternative sub¬
strates as inhibitors of ATP reduction at low ATP concentrations
eliminated the simple one-site model. Analysis of the inhibition
pattern of alternative substrates in the presence of their al¬
losteric effectors eliminated a two-site model with only one cat¬
alytic site. Substrate saturation studies, then, have suggested
that at least two nonidential interacting sites for substrate
binding exist and have indicated that in fact, more than two sites
may be necessary to account for the complex cooperative effects
observed.
Simultaneous Reduction of ATP and CTP:
The results from the previous kinetic studies supported as¬
signment of at least two nonidentical substrates sites to the
ribonucleotide reductase enzyme. The observed negative and positive
cooperativity of ATP and CTP reduction demonstrated that the two
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sites interact in substrate binding and catalysis. The data from
the substrate saturation curves {Figs. 26 and 27) showed that ca¬
talysis occurred at a slower rate when both substrate binding sites
were occupied. It was not clear, however, whether both substrate
sites were catalytic sites. If both of the substrate sites on the
enzyme were catalytic sites, one might expect that the enzyme could
reduce two substrates simultaneously. If the two-site model in
Scheme 5 is used, the assumption is that both ES and SE form product.
To examine the question of simultaneous reduction in this sys¬
tem, experiments were conducted in which various ratios of ATP and
CTP were used as substrates. The assays were conducted in duplicate
except that in one assay mixture ATP was radioactively labeled and
CTP was unlabeled, and in the other mixture CTP contained the
radioactive label while ATP was unlabeled. Each reaction mixture
contained the allosteric activators required for reduction of CTP
and ATP (dATP and dGTP, respectively).
The results are shown in Table 8. Under the experimental con¬
ditions employed, both substrates were reduced simultaneously, al¬
though at different levels. The rate of CTP reduction was higher
in the control containing only CTP, when compared to the rate of
ATP reduction in the control containing only ATP. If separate,
independent sites existed (one each for reduction of ATP or CTP)
then the total velocity of substrate reduction when both substrates
were present should be equal to the sum of the velocities for
reduction of each substrate alone. The total velocity observed
when both substrates were present was, at each combination of ATP
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1.0:0.0 1.08 0.00 1.08
0.0:1.0 0.00 1.30 1.30
1.0:1.0 0.66 0.92 1.58
0.5:1.0 0.40 0.76 1.16
1.0:0.5 0.78 0.50 0.128
^Reduction of the ^^C-labeled substrate was carried out in reac-
tion mixtures containing 1 mg protein, 0.2 mM dATP and 0.9 mM dGTP.
A substrate concentration of 0.6 mM was used as 1 in the ratio.
Reactions were incubated at 30° for 3 min.
^Velocity = nmol dATP/min/mg
^Velocity = nmol dCTP/min/mg
‘^Total velocity = (nmol dATP + dCTP)/min/mg
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and CTP concentrations, less than the sum of the velocity of CTP
plus the velocity of ATP from the controls. This demonstrated that
the two sites were not independent sites and confirmed results of
substrate inhibition studies which showed cooperativity.
Effect of Allosteric Effectors on Reduction of ATP:
Results from photoaffinity labeling studies using deoxyribonu-
cleotides to identify the allosteric binding sites of the ribo¬
nucleotide reductase enzyme indicated that two allosteric binding
sites are present on the enzyme. The previous kinetic studies
showed that in the presence of their allosteric effectors, the
alternative substrates of the ribonucleotide reductase enzyme acted
as mixed-type inhibitors, rather than partial competitive inhibi¬
tors of ATP reduction. It was therefore of interest to determine
whether competition of deoxyribonucleotides for the allosteric
effector site(s) contributed to the inhibition of ATP reduction
observed in the presence of alternative substrates and alterna¬
tive effectors.
In order to investigate the effect of the alternative deoxy-
ribonucleotide allosteric effectors on reduction of ATP, ATP
reduction was measured in assay series containing either 0.2 mM
dATP, 0.3 mM dTTP, or 0.2 mM dCTP in addition to 0.9 mM dGTP. The
control series contained only 0.9 mM dGTP. The results are shown
in Fig. 30 and quantitated in Table 9. Both dATP and dTTP caused
inhibition in which the for ATP reduction was increased by 27%
and the was decreased by 8%. dCTP caused the K^, and the
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Figure 30. Effect of allosteric effectors on reduction of ATP. ATP
saturation curves were constructed from assay mixtures
containing 0.06 - 0.6 mM [1^C]ATP, 0.9 mM dGTP, and
deoxyribonucleotides as indicated. Concentrations used
were: dATP - 0.2 mM; dTTP - 0.3 mM; and dCTP - 0.2 mM.
A. Hyperbolic curve fit to observed data; B. Double¬
reciprocal plot fit to K^, and B - No addition,
• - dATP, ▲ - dTTP, ^ - dCTP.
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Table 9. Kinetic Parameters for Inhibition of ATP Reduction by
Allosteric Effectors^
Addition to
Assay Series *^m '^max
Inhibition
(Apparent)
Control none 0.15 1.2 —
dATP 0.19 1.1 competitive
dTTP 0.19 1.1 competitive
dCTP 0.13 1.0 uncompetitive
^Values were obtained from data in Figure 30.
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the to decrease by 16%, Since photoaffinity labeling studies
showed that deoxyribonucleotides compete for the same binding sites,
the inhibition observed was attributed to competition of dATP and
dTTP with dGTP for binding at the allosteric site(s). dCTP ex¬
hibited uncompetitive inhibition which could reflect its poor
binding to the allosteric binding sites. The decrease in the
of ATP reduction caused by the allosteric effectors in the absence
of the alternative substrates was relatively small (8%) when com¬
pared to the effect of effectors and alternative substrates present
simultaneously (c.f. Fig. 23 and Table 6; the was decreased
by 17%, 21%, and 51% by GTP plus dTTP, UTP plus dATP, and
CTP plus dATP, respectively.) From these results one may conclude
that interactions between the allosteric and substrate binding
sites result in the complex kinetics observed when alternative
substrates and alternative effectors are present simultaneously.
Effect of Various Fixed Concentrations of dATP on ATP Reduction:
Photoaffinity labeling studies with dGTP demonstrated two al¬
losteric binding sites on the enzyme, and photoaffinity labeling
with dTTP suggested that the two sites had different affinities for
binding of deoxyribonucleotides. In the labeling studies, dATP
competed dGTP labeling at sites on the 82 K and 78 K polypeptides.
Since dATP is the product of ATP reduction and therefore accumu¬
lates during the reaction it was of interest to determine whether
dATP inhibition of ATP reduction was dependent on the dATP
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concentration. ATP reduction was measured in assay series which
contained dATP at fixed concentrations of 0.1, 0.2, or 0.4 mM in
addition to 0.9 mM dGTP. The control series contained only 0.9 mM
dGTP.
The resulting saturation curves and double-reciprocal plots of
the data are shown in Fig. 31 and quantitated in Table 10. At con¬
centrations of 0.2 and 0.4 mM, dATP increased the apparent of
ATP reduction by 32% and 100%, respectively, demonstrating ap¬
parent competitive inhibition. A dATP concentration of 0.1 mM
actually decreased the apparent K^, by 22%.
These results demonstrated that at the low concentration of
dATP produced during the reaction (<0.1 mM) the inhibition of ATP
reduction by competition between dATP and dGTP for binding at the
allosteric sites is not a factor. Since the reaction is irreversi¬
ble, product inhibition by a back reaction can also be eliminated.
Effect of Variable dGTP on ATP Reduction:
Photoaffinity labeling studies provided evidence that two
distinct allosteric binding sites exist on the ribonucleotide
reductase enzyme. In order to obtain kinetic data to support the
two-site model for binding of dGTP to the enzyme, a dGTP saturation
curve was constructed. ATP reduction was measured in assays which
contained 0.6 mM ATP and 0 to 2 mM dGTP. The results are shown in
Fig. 32. The rate of ATP reduction increased as the concentration
of dGTP was increased up to 0.2 mM. Beyond 0.2 mM dGTP, the rate
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Figure 31. Effect of various fixed concentrations of dATP on ATP
reduction. ATP reduction was measured in assay series
containing 0.06-1.0 mM [^^C]ATP, 0.9 mM dGTP, and dATP
as indicated. A. Hyperbolic curve fit to observed
data; B. Double-reciprocal plot fit to and
• - No dATP, ■ - 0.1 mM dATP, A - 0.2 mM dATP,
^ - 0.4 mM dATP.
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Table 10. Kinetic Parameters for Inhibition of ATP Reduction by
dATp3
Addition to
Assay Series Km■'m '^max
Inhibition
(Apparent)
Control none 0.09 0.35 —
0.1 mM dATP 0.07 0.33 none
0.2 mM dATP 0.11 0.33 competitive
0.4 mM dATP 0.20 0.33 competitive









0. .5 1. 1.5 2.
dGTPCniTI)
Figure 32. Effect of variable dGTP on ATP reduction. ATP reduction
was measured in assay mixtures containing 0.6 mM
[^^C]ATP and 0 - 2 mM dGTP. A. Saturation curve; B.
Hill plot for [dGTP] range of 0-0.2 mM; C. Hill plot
for [dGTP] range of 0.2-2 mM.
Ill
of ATP reduction decreased as the concentration of dGTP was in¬
creased. This suggested that two sites with different binding
affinities for dGTP existed on the enzyme. Hill plots of the data
were curved, but by taking only those points between 0 and 0.2 mM
or 0.2 and 2 mM, nearly linear Hill plots were constructed (Fig.
32B and 32C). The slope of the Hill plot measured at low dGTP was
0.5 and the slope of the Hill plot measured at high dGTP was 0.8.
Values of less than one for the slopes of the Hill plots suggested
that binding of dGTP to the enzyme exhibited negative cooperativi-
ty.91,92 Inhibition of ATP reduction at high dGTP concentra¬
tions provided evidence for a low affinity effector binding site
which acts as an inhibitory site.
Effect of Variable dATP on CTP Reduction:
Since the dGTP saturation curve in the previous experiment
demonstrated inhibition of ATP reduction at high dGTP concentra¬
tions, it was of interest to determine whether high concentrations
of dATP would inhibit CTP reduction. CTP reduction was measured in
assays which contained 0.6 mM CTP and 0 to 2 mM dATP. The results
are shown in Fig. 33. The rate of CTP reduction increased as the
dATP concentration was increased up to 0.1 mM. At concentrations
of dATP higher than 0.1 mM, the rate of CTP reduction decreased.
A Hill plot of the data from this experiment was nonlinear and the
slope could not be determined. The similar results obtained for
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Figure 33. Effect of variable dATP on CTP reduction. CTP reduction
was measured in assay mixtures containig 0.6 mM [^H]CTP
and 0-2 mM dATP. A. Saturation curve; B. Hill plot.
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sites having different kinetic constants exist on the ribonucleotide
reductase enzyme.
CTP Reduction as a Function of Cofactor Concentration:
Since photoaffinity labeling studies showed that the cofactor,
DMBC, stimulated labeling of the 82 and 78 K polypeptides by both
dTTP and dGTP, this experiment was performed in order to examine
the effect of DMBC concentration on enzyme activity. The results,
shown in Fig. 34, demonstrated the absolute dependence of CTP re¬
ductase activity on DMBC concentration. In the absence of DMBC no
activity was observed. The for DMBC was very small at 3.6 x
10"^ M, indicating a high affinity of the enzyme for binding of the
cofactor. The Hill plot of the data was sigmoidal with a slope of
1.3. This nonintegral value for the slope of the Hill plot suggest¬
ed that more than one binding site for DMBC existed on the enzyme
and that binding of DMBC at these sites was cooperative. In kinetic
studies of the ribonucleotide reductase from L. leichmannii Vitols
et al.^^ observed that the binding of deoxyribonucleotide effectors
lowered the K^, of DMBC binding, suggesting a cooperative effect
between binding of deoxyribonucleotide effectors and the cofactor,
DMBC. The apparent cooperativity of DMBC binding to the ribonucleo¬
tide reductase from P. stutzeri may also have been the result of
cooperativity between binding of deoxyribonucleotides and DMBC.
Cooperativity was suggested by the observed stimulation of deoxy¬
ribonucleotide binding to the putative allosteric binding sites of
the enzyme during photoaffinity labeling in the presence of DMBC.
nmoldCTP/min/mg
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Figure 34. CTP reduction as a function of DMBC concentration. CTP
reduction was measured in assay mixtures containing 0.4 mM
[^H]CTP, 0.15 mM dATP, and 0-4 #xM DMBC. A. Saturation
curve; B. Hill plot.
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Immunological Studies
Polyclonal antibodies were raised against the P. stutzeri 82 -
78 K doublet protein which was identified in photoaffinity labeling
experiments as a putative allosteric subunit of the ribonucleotide
reductase enzyme. Immunological studies using the antibodies were
conducted in an attempt to show that the doublet polypeptides were
components of the P. stutzeri ribonucleotide reductase enzyme and
to identify other polypeptides which might comprise the enzyme.
Ouchterlony double diffusion experiments were conducted to
determine whether an antibody-antigen response would be obtained
between the antibody raised against the P. stutzeri doublet protein
and ribonucleotide reductase-containing lysates from various organ¬
isms. The aim was to show specificity of the antibody for the
ribonucleotide reductase protein. The results are shown in Fig.
35. A precipitin band was present on the plate containing the P.
stutzeri protein fraction and P. stutzeri antiserum (a). No
precipitin band formed between the P. stutzeri protein fraction
and normal rabbit (nonimmune) serum (b). Plates containing lysates
from either L. leichmannii (c) or Euglena gracilis (d) did not
show a positive antibody-antigen interaction with the P. stutzeri
antiserum. This experiment demonstrated that the antiserum pre¬
pared against the doublet protein from P. stutzeri was capable of
complex!ng a component of the P. stutzeri protein fraction, but
did not form a complex with the ribonucleotide reductase from other
organisms.
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Figure 35. Ouchterlony double immunodiffusion. The experiment was
carried out as described in the text. Antigens were added
to center wells and dilutions of serum to the outer wells
as follows: 1 - undiluted; 2 - 1:5; 3 - 1:10; 4 - 1:100;
5 - 1:500; 6 - 1:1000. Antigens used were: a. and b. P.
stutzeri protein fraction; c. L. leichmannii extract; d.
Euqlena extract. Antiserum produced against the £. stut¬
zeri doublet was used in a, c, and d. Nonimmune serum was
used in b.
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To determine whether the antibody raised against the doublet
protein could neutralize the ribonucleotide reductase activity from
the P. stutzeri protein fraction, a double immunoprecipitation as¬
say was performed. A protein fraction which had been solubilized
using Emulgen 911 detergent as described in "Methods" was used in
order to avoid nonspecific precipitation of the protein during
centrifugation of the immunocomplex. Following solubilization, the
ribonucleotide reductase activity remained in the supernatant when
centrifuged at 100,000 x g.
Samples of the solubilized protein fraction were titrated with
serial dilutions of the rabbit anti-doublet protein serum. Goat
anti-rabbit IgG was used as a second antibody in order to precipi¬
tate the rabbit antibody. Following centrifugation, supernatants
from the immunoprecipitated protein were assayed for CTP reductase
activity. Up to 70% of the CTP reductase activity was absent from
the supernatants of samples containing the antiserum, while only
10-20% of the activity in samples containing nonimmune serum was
pelleted (Fig. 36).
Western blot analysis of the protein fraction was performed to
determine which polypeptides in the protein fraction were immuno-
reactive with the antibody raised against P^. stutzeri. Polypep¬
tides with molecular weights of 160, 150, 115, 100, 83, 78, and 60
K were recognized by the antiserum (Fig.37A, lane 1). Other minor
polypeptide bands were also present on the immunoblot, and the
background was quite high.
JiREDUCTftSEACTIUITY
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Figure 36. Immunoprecipitation of ribonucleotide reductase activity.
Samples containing 0.5 mg of protein fraction were incu¬
bated with 0-3 mg of serum protein. Goat anti-rabbit
IgG was added and samples were incubated overnight at 4°.
The precipitated protein was removed by centrifugation,
and the CTP reductase activity remaining in the super¬
natant was determined. The activity remaining was cal¬
culated as the percent of the activity obtained in a




Figure 37. Western blot analysis. Protein was separated by SDS-PAGE
and transferred to nitrocellulose as described in the
text. Western blot analysis was performed using primary
antisera at 1:50 dilutions. A. 7% SDS-PAGE of P. stut-
zeri protein fraction analyzed as follows: lane 1 - P.
stutzeri antiserum, lane 2 - nonimmune serum, and lane 3
- Euqlena antiserum. B. 10% SDS-PAGE of extracts treated
with P. stutzeri antiserum: lane 1 - India ink stain of
P. stutzeri protein fraction, lane 2 - P. stutzeri pro¬
tein fraction, lane 3 - Euqlena extract, and lane 4 - L.
1 eichmannii extract.
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In order to determine whether recognition of any of the poly¬
peptides resulted from nonspecific binding by the antiserum,
several experiments were conducted. First, Western blot analysis
was conducted using nonimmune serum as the primary antibody instead
of the P. stutzeri antiserum. In this experiment the 60 K polypep¬
tide was recognized by the nonimmune serum (Fig. 37A, lane 2),
suggesting that the 60 K polypeptide was being complexed by some
endogenous component present in both the nonimmune serum and the P.
stutzeri antiserum. In the second experiment, antiserum produced
against the Euqlena ribonucleotide reductase was used as the pri¬
mary antibody. The results of that experiment showed that most of
the polypeptides recognized by the £. stutzeri antiserum were also
recognized by the Euqlena antiserum (Fig. 37B, lane 2). While the
majority of the polypeptides were complexed to the same extent with
antisera from both Pseudomonas and Euqlena. binding of the P.
stutzeri antibodies to the doublet (82-78 K) polypeptides appeared
to be more intense (Fig. 37A, lanes 1 and 3). Analysis of crude
extracts from Euqlena and L. leichmannii using the £. stutzeri
antiserum showed that none of the polypeptides of the Euqlena
extract, and only the 100 K polypeptide of the L. leichmannii ex¬
tract were recognized by the £. stutzeri antibodies (Fig. 37B,
lanes 3 and 4).
These results demonstrated that the antiserum prepared against
the doublet polypeptide of £. stutzeri was capable of cross react¬
ing with many of the polypeptides in the £. stutzeri protein frac¬
tion preparation, as well as one polypeptide in the L. leichmannii
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extract. Furthermore, many of the polypeptides in the P. stutzeri
preparation were also recognized by the antiserum against the
purified Euglena ribonucleotide reductase. The objective of the
immunological studies was to show that the doublet protein was a
component of the £. stutzeri ribonucleotide reductase enzyme.
While the results of these studies have raised many more questions
than they have answered, they have shown that antiserum produced
against the stutzeri doublet protein is able to complex with the
enzyme to neutralize most of the ribonucleotide reductase activity.
DISCUSSION
Photoaffinity labeling has been used to make an initial iden¬
tification of polypeptide chains that comprise the ribonucleotide
reductase protein from P. stutzeri. These experiments were carried
out using the membrane-associated protein preparation. In previous
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studies it was demonstrated that the ribonucleotide reductase
activity is tightly bound to membrane components in P. stutzeri.
Some researchers have postulated that the purified, isolated ribo¬
nucleotide reductase enzyme may not present a true picture of the
in vivo enzyme, and that jn vivo the enzyme may exist as a compo-
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nent of a DNA synthesizing complex. Allen et al. isolated such
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a complex from T4 phage. Reddy and Pardee coined the term
"replitase" to describe the complex of enzymes responsible for
synthesis of deoxyribonucleotides and channeling of these deoxyri-
bonucleotides into the DNA of CHEF/18 cells. The complexes from
T4-phage and CHEF/18 cells were found to contain ribonucleotide
reductase. Since separation of the P. stutzeri ribonucleotide
reductase enzyme from membrane components results in a loss of
activity, we believe that the membrane-associated complex may be
more representative of the true environment in which reduction of
ribonucleotides by P. stutzeri ribonucleotide reductase occurs in




In an attempt to localize the allosteric binding sites of ri¬
bonucleotide reductase, photoaffinity labeling using allosteric
site-directed deoxyribonucleotide probes was employed. The specifi¬
city of the photoaffinity labeling of allosteric sites on the
enzyme was judged by the following criteria: 1) labeling was com¬
peted by deoxribonucleotides known to be allosteric effectors of
the reductase, but not by substrates or deoxynucleoside monophos¬
phates; 2) labeling was enhanced by the enzyme's cofactor, DMBC;
and 3) labeling was stimulated by addition of substrates. Similiar
criteria were used by Caras and associates'®’®^ to demonstrate
specificity of labeling of the allosteric site on the Ml subunit of
mouse ribonucleotide reductase using dTTP and dATP. Although
neither of these studies investigated the effect of cofactor on
labeling of the allosteric site by these deoxyribonucleotides,
Caras et al.®^ found that labeling of the catalytic site on th Ml
subunit of mouse ribonucleotide reductase using CDP required the M2
subunit which contains the iron-tyrosyl radical cofactor. Kinetic
studies of the reductase from L. leichmannii showed that binding of
deoxynucleotide effectors lowered the for DMBC binding, suggest¬
ing a cooperative effect between cofactor and allosteric effec¬
tors.^^ It is reasonable, therefore, to suggest that the enhanced
deoxyribonucleotide binding observed in the presence of DMBC result¬
ed from cooperative binding at the respective sites on the enzyme.
The ability of substrates to stimulate labeling of the doublet
by dGTP was unexpected. However, similiar findings have been report¬
ed. During labeling of the B1 subunit of the E. coli ribonucleotide
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reductase with dTTP, Eriksson®^ observed a 3-fold stimulation of
dTTP labeling of the allosteric site by dTTP in the presence of
GDP, the substrate for which dTTP is a positive effector. In our
study ATP stimulated dGTP labeling of the doublet 15-fold. The
similiar allosteric effects observed in our experiments support the
conclusion that the 82-78 K doublet polypeptides labeled by dGTP
contain allosteric binding sites of the ribonucleotide reductase
protein.
In studies using dTTP as the photoaffinity label we observed
the incorporation of radioactivity into material, near the top of
the gel, which did not stain as protein bands. The labeling was
found to be alkaline-labile as evidenced by its absence from gels
in which samples were incubated in pH 10 buffer prior to electro¬
phoresis (see Figure 2). Although the mechanism of photoincorpora¬
tion of dTTP into proteins is not clearly understood, studies have
shown that photolysis of dTTP in the presence of cyteine or trypto¬
phan leads to adduct formation.^®’^^ The formation of thymi¬
dine dimers upon exposure of DNA to UV light is a well known event.
One explanation for the alkaline-labile labeling of "nonprotein"
material in the P. stutzeri protein fraction is the formation of
thymidine-cytidine (T-C) dimers between the [^^P]dTTP and RNA
present in the protein preparation. In studies of pyrimidine dimer
formation, Lipphe et al.^® identified UV-induced, alkaline-labile
lesions consisting mainly of T-C dimers. Another, perhaps more
relevant explanation comes from the observation by Bayley and
Knowles^^ that in some cases, photolysis products can lead to a
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smear of radioactivity near the gel front on SDS-polyacrylamide
gels. They attribute this smear of radioactivity to labeled lipid.
Since our membrane preparation contains phospholipids, this latter
explanation would account for the observed dTTP labeling of mate¬
rial which migrates at the gel front.
Photoaffinity labeling of the P. stutzeri enzyme preparation
with [^^P]azido-ATP resulted in nonspecific labeling of several
polypeptides. Because of the highly reactive nature of the nitrene
formed when the azido moiety is irradiated with UV light, nonspeci¬
fic labeling can occur when binding of the ligand to the protein is
loose (Kjissoc ^ The of azido-ATP binding to the
enzyme as determined from kinetic studies was 4 x 10*^ M. This
value represents low affinity and weak binding of the azido-ATP
ligand to the enzyme. The nonspecific labeling by azido-ATP could
therefore have resulted from diffusion of the reactive species,
generated by photolysis of azido-ATP, out of the binding site be¬
fore covalent attachment to the enzyme could occur.
Specific labeling of the 57 K polypeptide by azido-ATP in the
presence of high concentrations of CTP suggested that this polypep¬
tide contained a substrate binding site of the ribonucleotide
reductase enzyme. CTP appeared to act allosterically to increase
the affinity of the enzyme for azido-ATP, thereby giving rise to
the observed intense labeling of the 57 K polypeptide. Kinetic
studies of the ribonucleotide reductase from various sources have
shown that in some cases one substrate can activate reduction of
another substrate. In studies of the mammalian ribonucleotide
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reductase, Cory et observed the activation of CDP and UDP
reduction by ADP. In studies of the simultaneous reduction of
substrates by L. leichmannii ribonucleotide reductase, Witt et
al.^®^ observed that ATP reduction was more than 4 times greater
in the presence of GTP than in its absence.
In kinetic studies designed to delineate the number of sub¬
strate binding sites on the P. stutzeri ribonucleotide reductase
enzyme, it was observed that the rate of reduction of both ATP and
CTP increased sharply to a second as the substrate concen¬
tration was increased beyond 2-3 mM. Analysis of these bumpy
substrate saturation curves using the Koshland rapid equilibrium
and the steady state treatments suggested that at least two non¬
identical substrate binding sites exist on the enzyme. The pre¬
sence of allosteric effectors play an important role in catalysis
of substrates, possibly by mediating conformational changes in the
enzyme. The two-site model for substrate binding can account for
the observed partial competitive inhibition in the presence of the
alternative substrates, and for the mixed-type inhibition which
occurred when the allosteric effectors for the alternate substrates
were added. In studies of the human lysosomal |3-glucosidase
Grabowski et al.^®^ observed partial competitive and mixed-type
inhibition patterns, as well as substrate inhibition. These authors
concluded that at least two binding sites were present on the
enzyme. Vitols et al.^^ found evidence for binding of ribonucleo¬
tides at two sites on the L. leichmannii ribonucleotide reductase.
In their study, nonlinear double-reciprocal plots were used as a
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basis for postulating that two distinct enzyme-substrate species
existed. They proposed that one species resulted from binding
of substrate at the catalytic site, while the other was the result
of substrate binding at an effector site. Our photoaffinity label¬
ing studies showed that substrates do not compete with binding of
deoxyribonucleotides at the allosteric effector binding sites. The
evidence, therefore supports the assignment of at least two dis¬
tinct substrate binding sites to the ribonucleotide reductase
enzyme.
The kinetic studies also showed that simultaneous reduction of
ATP and CTP can occur, although at different rates. Simultaneous
reduction of substrates by ribonucleotide reductase has been re¬
ported by other researchers. Vitols et al.^^ observed that
simultaneous reduction of ATP and CTP by L. leichmannii reductase
occurred at different rates under fixed assay conditions. They
attributed the difference in relative rates to differences in the
of DMBC required for reduction of the two substrates. The
of DMBC required for reduction of ATP and CTP by the P. stutzeri
enzyme was not compared in the investigation reported here. Witt
et al.^®^ observed that L. leichmannii reductase was capable of
simultaneous reduction of all four substrates. The relative rates
of reduction of the purine nucleotides (ATP and 6TP) were much
greater than those of CTP and UTP. In my study, the total rate of
reduction of ATP and CTP in reaction mixtures containing both
substrates was less than the combined velocities of the two sub¬
strates alone, but the rates of ATP and CTP reduction were
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comparable. The results demonstrated that the two substrate sites
are not independent sites but interact during reduction of ribonu¬
cleotide substrates by ribonucleotide reductase.
Since the kinetic studies suggested multiple substrate binding
sites, it is tempting to postulate that labeling of the 57 K poly¬
peptide by azido-ATP in the presence of high concentrations of CTP
is the result of crosslinking of two 57 K polypeptides by binding
of azido-ATP at substrate sites on the two polypeptides. Maruta
and Korn^® demonstrated the ability of unmodified ATP to directly
photolabel the catalytic site on Acanthamoeba myosins, indicating
that ATP contains an inherently photolabile moiety. Schafer et
al.^®^ demonstrated the ability to crosslink the a subunit (65
K) and the P subunit (55 K) of FjATPase from Micrococcus luteus
using 3'-arylazido-8-azido-ATP. The crosslinked product, a 120 K
polypeptide, could be detected on an SDS-polyacrylamide gel. It is
conceivable that photolysis of azido-ATP could result in a compound
with two active components which could then interact with binding
sites on two different enzyme molecules. Analysis of the protein
by SDS-PAGE would be expected to reveal two labeled species: the
single polypeptide (57 K), and the crosslinked dimer of the 57 K
polypeptide (114 K). The 57 K and 107 K polypeptides labeled by
azido-ATP in the presence of excess CTP had molecular weights
very close to the expected products of crosslinking during labeling.
Immunological studies using antiserum prepared against the 82-
78 K polypeptides from P. stutzeri were conducted in an attempt to
demonstrate these polypeptides as components of the ribonucleotide
129
reductase enzyme. Antiserum produced against the 82-78 K polypep¬
tides was capable of immunoprecipitating up to 70% of the CTP
reductase from protein fractions. An inability to obtain complete
titration of the enzyme activity from the protein fraction may have
resulted from use of amounts of the secondary antiserum which were
insufficient to facilitate optimal formation of the immunocomplex
matrix. To overcome this problem, the amount of secondary anti¬
serum was varied and a secondary antibody bound to a bead matrix
(Immunobeads obtained from Bio-Rad Labs) was used. In both cases,
complete immunoprecipitation of the ribonucleotide reductase acti¬
vity was not achieved.
Another explanation for the inability of the antiserum to com¬
pletely inhibit the CTP reductase activity is the possible exis¬
tence of multiple forms of the ribonucleotide reductase enzyme in
the protein preparation with antigenic determinants that are not
recognized by the £. stutzeri antiserum raised against the doublet
polypeptides. Studies have shown that during purification of the
enzyme from several mammalian sources multiple forms of the enzyme
can be detected.However, no direct evidence for multiple
forms of the P. stutzeri ribonucleotide reductase was obtained in
studies reported in this investigation.
In order to determine whether the antiserum raised against the
putative allosteric subunit polypeptides of P.stutzeri could recog¬
nize the ribonucleotide reductase from other sources, Ouchterlong
double diffusion was performed. The antiserum was tested against
the deoxyadenosylcobalamin-dependent reductases from Eualena and L.
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leichmannii. The results showed that the antiserum did not cross-
react with these reductases. Although the reductases from P.
stutzeri and these organisms are similar, there are significant
differences between them. The Euglena reductase is a eukaryotic
enzyme and has different regulatory properties from those of P.
24
stutzeri. The L. leichmannii reductase is a monomeric, cytoso-
13 14
lie enzyme. ’ These differences could cause the ribonucleo¬
tide reductases from these different sources to have different
antigenic determinants which could prevent their recognition by the
P. stutzeri antiserum.
Western blot analysis revealed that in addition to the 82-78 K
doublet polypeptides, several other polypeptides in the P. stutzeri
protein fraction were recognized by the antiserum. A 60 K polypep¬
tide which cross-reacted with P. stutzeri antiserum also cross-
reacted with antiserum raised against the Euglena ribonucleotide
reductase, as well as with nonimmune serum. This suggests that
binding of antiserum to this polypeptide was nonspecific.
Three possible explanations for identification of polypeptides
other than the 82-78 K doublet by the antiserum can be put forth.
First, these polypeptides could be components of the ribonucleotide
reductase and therefore be recognized by the antiserum. Secondly,
these polypeptides could share antigenic determinants with the
pc
antigen used to produce the antibody. Thelander et al. showed
that the M2 subunit of ribonucleotide reductase from mouse cross-
reacted with an anti-tubulin monoclonal antibody, suggesting common
antigenic determinants for the M2 subunit and tubulin. Finally, it
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is possible that the antigen used to produce the antiserum was
impure. In this case, antibodies against the contaminating antigen
could have also been produced. This third explanation seems a
likely one to explain the recognition of the 100 K polypeptide by
the antiserum. This 100 K polypeptide migrated close to the doub¬
let protein on SDS gels and could have been excised along with the
doublet and used in antigen preparation. Identification of the
higher molecular weight polypeptides by the antiserum is more
likely the result of common antigenic determinants since these
bands were not in close proximity to the doublet protein on SDS
gels used for antigen preparation. In any case, the possibility
that some of these polypeptides may also be components of the
ribonucleotide reductase protein cannot be ruled out.
Extensive studies of the purified £. coli ribonucleotide re¬
ductase have shown that the enzyme is composed of two subunits,
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identified as B1 and B2. The B1 subunit is reported to contain
two polypeptide chains that differ slightly in their molecular
weights, which appear to be in the range of 77 K. The two polypep¬
tides are reported to have identical COOH-terminal amino acids but
different NH2-terminal amino acids, and have been designated aa'
The B2 subunit is reported to contain two identical polypeptides
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with molecular weights of 39 K. Carlson et al. have cloned and
sequenced the nrd A and nrd B genes that code for the ribonucleo¬
tide reductase polypeptides in E. coli K-12, and have identified
two open reading frames that could yield polypeptides of molecular
weights 87,532 and 43,355 daltons, respectively. The authors
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suggest that the nrd A gene translation product could be processed
to yield an additional polypeptide of 84,490 daltons. These two
products of the nrd A gene appear to agree with the published amino
12
acid composition of the a and a' polypeptides of the B1 subunit.
We suggest that data in this report will allow for a P1,P2
subunit composition for P. stutzeri ribonucleotide reductase iden¬
tical to the B1,B2 composition for E. coli as described above. We
suggest that the P. stutzeri PI subunit is composed of the 82 K
and 78 K polypeptides to give a combined molecular weight of 160 K
which is identical to the size of the E. coli B1 subunit. The P2
subunit would then be composed of two 57 K polypeptides with a com¬
bined size for the dimer of 107 K.
CONCLUSIONS
The objective of the research described in this dissertation
was to study the structural and kinetic properties of the ribonu¬
cleotide reductase enzyme which is a component of a multi-protein,
membrane-associated complex isolated from P. stutzeri. Within the
realms of this objective, the specific aims were to identify the
polypeptides comprising the enzyme, and to identify the substrate
and allosteric binding sites on these polypeptides. To achieve
these objectives, novel methods were employed because of the
membrane-associated nature of the enzyme. The structural features
of the enzyme were studied using the technique of photoaffinity
labeling. Deoxyribonucleotides were employed as allosteric site-
directed probes. The substrate site was studied using 8-azido-ATP,
an analog of ATP. To identify the number of allosteric and sub¬
strate binding sites on the enzyme, kinetic studies were used.
Finally, immunological studies were employed, using an antiserum
produced against the polypeptides identified by photoaffinity
labeling studies as containing allosteric sites of the enzyme. The
immunological studies were aimed at confirming results from the
photoaffinity labeling studies.
Based on studies undertaken in this investigation, some fea¬
tures of the ribonucleotide reductase enzyme from P. stutzeri can
be presented. The proposed model for the enzyme consists of two
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subunits. The allosteric subunit is proposed to be comprised of
two polypeptides of 82 K and 78 K which contain two distinct al¬
losteric binding sites. The 82 K polypeptide contains an allo¬
steric site which binds dTTP, dGTP, and dATP. This site is a high
affinity site, and binds deoxyribonucleotides when they are present
at lower concentrations. The 78 K polypeptide contains an allo¬
steric site which binds dGTP and dATP. When present at high con¬
centrations dTTP is bound to this site. It appears to be a low
affinity site, binding deoxyribonucleotides when they are present
at higher concentrations. dCTP can weakly bind to both the 82 K
and the 78 K polypeptides. Binding of effectors at the low affi¬
nity site results in apparent inhibition of the reduction reaction.
The catalytic subunit is proposed to be comprised of two 57 K
polypeptides which may contain at least two distinct substrate
binding sites. The substrate binding sites exhibit a complex
pattern of negative and positive cooperativity which suggests
comformational changes resulting from substrate binding. Competi¬
tion studies from photoaffinity labeling with deoxyribonucleotides
establish that the substrate binding sites are unique from the
allosteric effector sites occupied by deoxyribonucleotides.
Taken together, these results can be used to suggest a P1,P2
model for the P. stutzeri ribonucleotide reductase enzyme which is
similar to the B1,B2 model for the ribonucleotide reductase enzyme
from E. coli. The PI subunit is the allosteric subunit and is
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comprised of the 82 K and 78 K polypeptides. The P2 subunit is
the catalytic subunit and is comprised of two 57 K polypeptides.
Although many unanswered questions are posed by the suggestion
of a similarity in the structures of the E. coli and P. stutzeri
ribonucleotide reductase enzymes, the possibility of structural
relatedness between the two very different enzymes is intriguing
and should provide impetus for additional experiments to unveil new
information about the structure of the enzyme in the two organisms.
The results reported in this dissertation should lay the ground
work for continued investigations into the complex structural and
kinetic properties of the ribonucleotide reductase from P.
stutzeri.
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